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ABSTRACT 
 
The overall objective of this thesis was to investigate the vitrification of bovine cumulus oocyte 
complexes (COCs) as a tool for conservation of female genetics.  Specifically, the first objective 
was to compare in vitro maturation rates (i.e. end point Metaphase II (MII) rate) of bovine COCs 
following vitrification using two different equilibration times (0 vs 10 min) in vitrification 
solution 1 (VS1) and two different cryodevices (cryotop vs 0.25 mL straw).  The MII rate was 
higher in the non-vitrified control group than in vitrified groups (61 vs 16%, P<0.001). In the 
vitrified groups, equilibration time in VS1 [TCM-199 + 7.5% ethylene glycol (EG) + 7.5% 
dimethyl sulfoxide (DMSO) + 20% calf serum (CS)] did not affect MII rate (P=0.964); however, 
MII rate was higher in COCs vitrified on cryotops than in straws (23 vs 9%, P=0.007).  
 
The second objective of this thesis was to compare cleavage and subsequent developmental 
competence of bovine COCs vitrified using different vitrification solutions (fresh vs frozen) and 
different equilibration times in VS1 (0 vs 5 min).  Immature bovine COCs were vitrified on 
cryotops using vitrification solutions either prepared fresh or frozen/thawed, and two 
equilibration times in VS1 (0 vs 5 min).  Cleavage and blastocyst production rates were higher 
(P<0.001) in the non-vitrified control group than vitrified groups (cleavage rate 93 vs 42% and 
blastocyst rate 31 vs 0.4%).  The cleavage rate of COCs vitrified in frozen/thawed solutions with 
5 min equilibration was higher (P=0.05) than in other treatment groups.  However, the blastocyst 
rate did not differ (P=0.993) among vitrified groups.   
 
We hypothesized that the nuclear stage of bovine COCs at the time of vitrification will affect 
post-warming in vitro maturation (IVM), cleavage and embryo development.  Firstly, a 
preliminary study was conducted to validate our in vitro maturation system.  The COCs were at 
germinal vesicle (GV, 89%), germinal vesicle breakdown (GVBD, 47%), metaphase I (MI, 
90%), and metaphase II (MII, 84%) stages at 0, 6, 12 and 22 h of IVM respectively.  In a 
subsequent study, bovine COCs were vitrified after 0, 6, 12 and 22 h of IVM by loading on 
cryotops and plunging in liquid nitrogen.  Following 1 min in warming solution (TCM-199 + 
17% sucrose + 20% CS), COCs were placed in IVM medium to complete 22 h of IVM and 
nuclear stages were evaluated using lamin A/C-DAPI staining.  The nuclear maturation (MII) 
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rates of COCs were 23, 23, 35 and 89% (P<0.001) in the 0, 6, 12 and 22 h IVM groups, 
respectively.  In the final nuclear stage experiment, cleavage and embryo development was 
determined after vitrification of COCs after 0, 12 and 22 h of IVM.  The cleavage and blastocyst 
rates were higher (P<0.001) in the non-vitrified (control) group than vitrified groups (73 vs 15% 
and 22 vs 0.3%, respectively). The cleavage rates (14% in 0 h, 17% in 12 h and 14% in 22 h 
groups; P=0.825) and blastocyst rates (0% in 0 and 22 h and 1% in 12 h groups) did not differ.  
Results from this study indicated that a greater proportion of COCs progressed to MII if 
vitrification occurred at MI rather than at GV and GVBD stages.  However, the nuclear status of 
vitrified COCs appeared to have no effect on fertilization or subsequent embryo development.   
   
 A final set of experiments were designed to determine if the exposure of bovine COCs to 
cryoprotectant solutions and different warming time intervals affects their ability to become 
fertilized, cleave and develop into blastocysts.  In both experiments, the cleavage and blastocyst 
rates in the vitrified group were lower (P<0.001) than in the non-vitrified control groups VS1 
group, and in the VS1 + vitrification solution 2 (VS2; TCM-199 + 15% EG + 15% DMSO + 
20% CS) group.  However, the cleavage and blastocyst rates did not differ (P>0.05) in control, 
VS1 and VS1+VS2 groups.  In the second experiment, there was no difference in cleavage rates 
between 1 and 5 min intervals in the warming solution.   
 
In conclusion, cryotop can be used as a preferred cryodevice for vitrification of bovine COCs.  
Vitrification solutions (VS1 and VS2) and the warming solution can be prepared and stored in 
the freezer (-20 °C) for convenience.  The pre-equilibration of bovine COCs in VS1 had no 
effect on the nuclear maturation of vitrified/warmed COCs, but 5 min pre-equilibration in VS1 
improved cleavage rates.  The nuclear stage of COCs at the time of vitrification and 
cryoprotectant exposure appeared to have no effect on subsequent cleavage.  Furthermore, there 
was no difference in cleavage and blastocyst rates following vitrification and 1 or 5 min warming 
time intervals.  When compared to non-vitrified controls, the vitrification of immature bovine 
COCs resulted in reduced nuclear maturation, cleavage and embryo development rates.  Further 
studies are needed to elucidate the causes of the poor embryo development in vitrified-warmed 
bovine COCs at genomic, proteomics and metabolomics levels. 
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CHAPTER 1: INTRODUCTION  
 
Many domestic breeds of livestock are experiencing a gradual diminishment of genetic diversity, 
mainly due to the selection of few breeds, or lines within breeds, to meet the market demand.  
However, it is in the interest of the international community to conserve livestock genetic 
diversity for food security and as an insurance policy against global climate change, disease 
threats, social changes and unforeseen catastrophes [1, 2].  Ideally, populations could be 
preserved as live animals; but this is expensive and unless animals can be used for production, is 
not likely to succeed [2].  Therefore, in vitro conservation strategies are being developed to 
preserve animal genetic resources for long term storage in gene banks that can be used at a later 
time to regenerate a particular population [3, 4].     
 
Conservation programs have focused efforts on the cryopreservation of gametes, embryos, 
somatic cells and testis and ovarian tissue.  Although considerable progress has been made in 
both semen and embryo cryopreservation of several domestic species, oocytes are extremely 
sensitive to chilling and to date, a standardized procedure for the cryopreservation of mammalian 
oocytes has not been established.  Long term storage of oocytes would allow for the development 
of ova banks, permitting female genetic material to be stored unfertilized until an appropriate 
mate is selected.  Successful cryopreservation of oocytes would allow for the preservation of 
genetic material from unexpectedly dead animals and would facilitate many assisted 
reproductive technologies [5-7].  
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During cryopreservation, oocytes suffer considerable morphological and functional damage; 
however, the extents of cryoinjuries are highly variable depending on species, sensitivity of the 
cell structure to cooling, meiotic stage, lipid content and origin (in vitro and in vivo) [5].  The 
parameters such as temperature and the permeability, toxicity and time of exposure to 
cryoprotectants should be taken into account while freezing oocytes [6].   
 
Although the specific molecular pathways disrupted during cryopreservation are not well 
understood, organelles critical to maintenance and development are damaged.  The major 
impairments in oocytes incurred during freezing procedures are due to ice crystal formation and 
osmotic injury [8].  Strategies to minimize cryoinjuries during freezing are based on the 
utilization of optimal cryoprotectants and cooling-warming rates.  Numerous cryoprotectants 
such as dimethyl sulfoxide (DMSO), glycerol and ethylene glycol (EG) have been utilized in the 
cryopreservation of mammalian embryos and oocytes [6].  Currently, conventional slow-
controlled freezing and vitrification are the two main methods being explored for oocyte 
cryopreservation.  During slow-controlled freezing, controlled cooling rates avoid changes in cell 
shape and osmotic effects by allowing extra- and intra-cellular fluid exchange; however, this 
method commonly leads to ice crystallization and cell damage.  Slow freezing is less successful 
in species whose oocytes are sensitive to chilling such as cattle, horses, sheep and pigs, as 
opposed to species such as mice, cats and humans, whose oocytes are less prone to chilling 
injury.  Furthermore, equipment requirements and exposure to cryoprotectants for extended 
periods of time are major limitations [9].  Vitrification is an alternative method of 
cryopreservation in which cells are exposed to a higher concentration of cryoprotectants and 
frozen at an ultra rapid rate.  This method of cryopreservation results in a solid glass like 
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structure and minimal intra-cellular ice crystal formation due to the viscosity of the highly 
concentrated cryoprotectant used in vitrification solutions and the rapid freezing rate [5].  At 
present, vitrification is a popular method for cryopreservation of “hard to freeze” bovine 
embryos due to its simplicity and success rate; however, vitrification of bovine oocytes is still 
challenging due to their complex structure and sensitivity to chilling [10, 11].                    
 
The objectives of this study were to examine several different approaches to vitrification and 
examine the survivability of vitrified bovine cumulus oocyte complexes by in vitro maturation, 
fertilization and culture.       
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CHAPTER 2: LITERATURE REVIEW  
 
I.  CONSERVATION OF ANIMAL GENETIC RESOURCES   
 
2.1 Loss of farm animal genetic resources 
 
Phenotypic characteristics are often the foundation for dividing animals into species, which have 
great diversity.  The domestication of animals first began centuries ago with the dog and has led 
to the development of specific breeds defined as having “a common genetic background, 
physical appearance, and genetic stability” [12].  
  
Phenotypic and genotypic breed diversification has evolved from animals being kept in different 
environments, resulting in the selection for specific characteristics in various regions.   Animals 
kept in large groups have also contributed to breed diversification, which has led to indirect 
selection for specific traits such as behavior or disease resistance.  Moreover, breed diversity has 
arisen from animals being selected by humans for specific traits such as meat or milk in cattle, 
eggs or meat in poultry, and wool, meat or milk in sheep [2].   
  
In the last few decades farm animal genetic diversity has rapidly declined, mainly due to 
changing market demands and intensification of agriculture [1].  Agriculture is moving away 
from small production systems to large commercial systems and as a result, selection goals and 
production environments are now very similar throughout the world.  Modern reproductive 
technologies have allowed a large number of progeny to be produced from a single individual 
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and contemporary transport has enabled the distribution of germplasm around the world rapidly 
and efficiently.  Livestock diversity has also been diminished by many breeding programs 
carried out by national and international companies, which place intense selection pressure on 
few breeds [2]. 
 
According to the Food and Agriculture Organization (FAO) [2007], approximately 20% of the 
world’s breeds of cattle, goats, pigs, horses and poultry are currently at risk of extinction.  At 
least one livestock breed has become extinct per month over the past several years, resulting in 
its genetic characteristics being lost forever [13].  Figure 2.1 demonstrates the risk status of 
several livestock species.  Currently over 10% of cattle, pig, sheep and horse breeds are extinct 
resulting in loss of genetic diversity and potentially useful genes.         
 
In Canada, there are several cattle breeds whose survival and genetic diversity are currently 
threatened.  Table 2.1 demonstrates these breeds according to their risk status [14].  It is 
imperative to conserve and maintain animal genetic resources to ensure the ability to respond to 
selection plateaus, consumer demand changes but more importantly biosecurity, environmental 
and food safety risks by maintaining biodiversity and keeping alternative and potentially useful 
genes available in the gene pool for present and future use [1, 5, 15].       
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Figure 2.1 Percentage of the risk status of the world’s cattle, pig, sheep, horse and goat livestock 
breeds.  Critical: the total number of breeding males and females is less than or equal to 100. 
Critical maintained: critical populations for which active conservation programmes are in place 
or populations are maintained by commercial companies or research institutions. 
Endangered: the total number of breeding females is greater than 100 and less than or equal to 
1000 or the total number of breeding males is less than or equal to 20 and greater than five. 
Endangered maintained: endangered populations for which active conservation programmes are 
in place or populations are maintained by commercial companies or research institutions. 
Not at risk: the population has a large amount of breeding males and females and there is no 
threat of extinction. 
Extinct: there are no breeding males or breeding females remaining.  
Adapted from the FAO [16]. 
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Table 2.1 Risk status of cattle breeds. Adapted from Rare Breeds Canada [14].  
Status (annual registration of 
100% pure female stock) Breed 
Critical (1-25) Kerry, White Park, Lynch Lineback, Milking Shorthorn 
Endangered (26-75) Belted Galloway, Red Poll, Lincoln Red 
Vulnerable (76-250) Dexter, Canadienne, Galloway, Braunveih, Guernsey 
At Risk (251-750) Highland 
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2.2 Strategies for farm animal genetic conservation 
 
Increasing awareness on the reduction of breed diversity has prompted global efforts for 
conservation of threatened breeds through launching organizations such as Rare Breeds Canada, 
conferences like the Convention on Biological Diversity and programs such as the Canadian 
Animal Genetic Resources.  Efforts have focused on conservation of diminishing farm animal 
breeds for several reasons, e.g.; to keep potentially useful genes and gene combinations, to take 
advantage of heterosis, to overcome selection plateaus, as well as for cultural reasons, research 
and food security.  Maintaining genetic diversity also provides insurance against climate change, 
disease, changing availability of feedstuffs, social change, selection errors and unforeseen 
catastrophic events such as Chernobyl where the genetic diversity of many local breeds was 
threatened [2, 17, 18].   
  
The goals of conservation are to keep genetic variation as gene combinations in a reversible form 
and to keep specific genes of interest such as the Booroola fecundity gene in sheep [19].  In order 
to achieve these goals several steps are necessary.  First an inventory must be taken to assess and 
monitor the risk status of a breed in an ongoing basis by examining the number of breeding 
males and females, the overall breed numbers, the number of sub-populations and the trends in 
population size.  An evaluation of the stocks for phenotype and genotype must be done to 
determine the genetic distance of one group from another and the choice of breeds for 
conservation [2].   
 
2.2.1 In situ conservation 
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Ideally, populations should be saved as live animals through in situ conservation programs; 
however, this is expensive and unless the breed can be used for production, is not likely to 
succeed [2].  Hence, ex situ in vitro strategies have been developed to cryopreserve animal 
genetic resources. Genome resource banks create a global gene pool that can be used to manage 
the exchange of genetic diversity or regenerate a population decades or centuries later [3, 4].  
The Convention on Biological Diversity recommended that ex situ conservation be 
complementary to in situ conservation for farm animal genetic resources [20].      
     
2.2.2 Ex situ conservation 
 
One of the major issues surrounding genome banks is the amount and type of material that needs 
to be stored, which is a function of the intended future use of the material [20].  In order to avoid 
inbreeding, a gene bank of male and female genetics formed from the largest number of 
individuals would be ideal [21].  Ex situ in vitro conservation programs of livestock genetic 
resources have focused efforts on cryopreservation of gametes, embryos, somatic cells as well as 
testis and ovarian tissues, effectively lengthening the genetic lifespan of individuals in a breeding 
program even after death.  
  
2.2.2.1 Semen 
 
Semen is one of the most practical means of storing germplasm due its abundant availability and 
the ease of application [3, 16].  Stored spermatozoa could be introduced back into existing 
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populations either immediately or decades or centuries afterwards.  Stored frozen-thawed semen 
from genetically superior males of threatened livestock breeds could be used for artificial 
insemination (AI) or in vitro fertilization (IVF) and has the potential to protect existing diversity 
and maintain heterozygosity while minimizing the movement of living animals [1, 22].  Breed 
reconstruction solely from semen is possible through a series of back-cross generations; 
however, the entire genetics of the original breed will not be recovered, as semen 
cryopreservation only conserves 50% of genetics [20].   
 
Semen from most mammalian and a few avian species has been successfully frozen in the past 
several years [16].  However, semen from only highly selected males is cryopreserved, so not all 
diversity is being stored.  Furthermore, the protocols currently used to conserve semen are still 
sub-optimal and cannot be easily extrapolated across species [23].  Table 2.2 demonstrates the 
reported average global conception rates in several species following first service AI with 
frozen-thawed semen [16].  First service conception rates vary drastically between different 
breeding programs, but on average they are fairly high in cattle, pigs, goats and sheep.      
  
One of the concerns for semen banking in a conservation program is the number of doses that 
need to be stored.  According to the FAO [2007], the number of doses required to regenerate an 
individual, population or breed is a function of the number of doses needed per parturition, the 
expected lifetime production of fertile (refounder) females as well as the number of breeding 
males and females required in the reconstructed population.   
 
11 
 
Table 2.2 Average global conception rate in different species following first service artificial 
insemination (AI) with frozen-thawed semen.  Adapted from the FAO [16].   
Species Average global conception rates following first service AI (%) Number of inseminations 
Cattle 50-65 110 million 
Pigs 70-80 40 million 
Goats 50-80 (intrauterine) or 55-65 (cervical) 120000 
Sheep 50-80 (intrauterine) or 55-60 (cervical) 50000 
Horses 35-40 5000 
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The number of semen doses (D) required for breed construction can be calculated as 
 
D=dp * F * np 
 
where dp is the number of doses required per parturition, F is the total number of females to be 
inseminated and np is the anticipated number of parturitions per female [24].   
 
It is estimated that in order to conserve a breed from the bovidae family, 1000 semen doses from 
25 different males would have to be collected and stored.  Furthermore, to reconstruct a horse 
population of 25 females, the number of doses required would exceed 20000 [20, 25].  In the 
event that the number of doses available per male is low, the re-establishment of a breed may be 
more efficient by embryo transfer [16].     
 
2.2.2.2 Embryos 
 
Embryo cryopreservation allows the conservation of the full genetic complement of both dam 
and sire and has tremendous opportunities for maintaining heterozygosity and population 
integrity; but it is a more complex and costly procedure than semen cryopreservation.  Moreover, 
a large number of embryos would be required for complete reconstruction of a population and 
are unlikely to be available from donor females of endangered breeds [20].  It is anticipated that 
the collection and storage of 300 unsexed embryos from 90 donors would be required to 
reconstruct a cattle population; however, finding 90 donor females in an endangered breed would 
be very challenging and highly unlikely [24].      
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Embryos of virtually all mammals have been successfully frozen, thawed and transferred to 
synchronized recipient females in the past [16].  Table 2.3 demonstrates embryo sensitivity 
towards cryopreservation in different species, developmental stages and origins [5].  Embryos 
from species such as swine or equine are much more cryo-sensitive compared to bovine or ovine 
embryos.  Currently, the widespread use of embryo cryopreservation is limited to cattle, sheep 
and goats [26, 27].  Moreover, it is apparent that earlier stage and in vivo derived embryos 
withstand cryopreservation better than later stage and in vitro produced embryos.  Therefore, the 
current challenge is to develop a standardized protocol that can be applied to embryos of 
different species at various developmental stages [5, 16, 28].           
 
2.2.2.3 Oocytes 
 
Oocytes are the largest cells in the body, have a low surface to volume ratio and are surrounded 
by a zona pellucida.  Immediately adjacent to the oocyte are corona radiata cells that have long 
cytoplasmic extensions which penetrate the zona pellucida, ending in bulbous swellings closely 
associated with the oocyte membrane.  These processes and gap junctions are important in the 
metabolic cooperation between the oocyte and surrounding layers of granulosa cells, which form 
the cumulus oocyte complex (COC) (Figure 2.2) during the growth phase [10].  Gap junctions 
and cumulus cells play an important role in development of immature oocytes.  It has been 
shown that cyclic adenosine monophosphate (cAMP), which regulates oocyte maturation, 
originates from cumulus granulosa cells and as cAMP increases in granulosa cells, it also  
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Table 2.3 Differences of animal oocyte and embryo cryopreservation resistance among species, 
developmental stages and origin.  Adapted from Pereira and Marques, 2008 [5]. 
  More resistance Less resistance 
Species Bovine, ovine Porcine, equine 
   
Developmental stages 
Morula, YBL and 
BL Hatched BL and oocytes 
   
Origin 
In vivo-derived 
embryos 
In vitro-produced embryos, micromanipulated 
embryos 
YBL=young blastocyst; BL=blastocyst  
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 increases in oocytes [29].  Therefore, osmotic stress on COCs, resulting from the addition and 
removal of cryoprotectants during cryopreservation techniques may affect oocyte development.     
 
The COCs collected in vivo using ultrasound-guided transvaginal retrieval or at slaughter can be 
frozen for extended periods of time for increased flexibility in their utilization for breeding 
programs.  Oocyte banks would enlarge the gene pool, facilitate several assisted reproductive 
procedures, salvage female genetics after reproductive failure or unexpected death and avoid 
controversy surrounding the preservation of embryos [6, 7].  Like semen and embryos, oocyte 
cryopreservation is beneficial for international exchange of germplasm, as it avoids injury and 
sanitary risks involved in live animal transportation [5].   
 
The subcellular components of oocytes are extremely temperature and osmotically sensitive.  
Oocyte cryopreservation is not as established as in semen or embryos, due to the fact that 
oocytes have a complex subcellular structure and typically have a lower permeability to water 
and cryoprotectants [23].  The major differences between oocytes and embryos are the plasma 
membrane, presence of cortical granules and spindle formation at metaphase II (MII) stage of 
meiosis in oocytes [30].  To date, there has been no consistent oocyte cryopreservation method 
established in any species.  However, there has been significant progress and offspring have 
reportedly been born from frozen-thawed oocytes in cattle, sheep and horses [31, 32].  In large 
part, the inability to successfully cryopreserve oocytes can be attributed to the lack of 
understanding of the basic cryobiological factors that determine survival or death following 
freezing.  During the process of cryopreservation, oocytes suffer considerable morphological and 
functional damage; although, the extent of cryo-injuries depends on the species and the origin (in  
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Vitelline membrane
Oocyte
Polar body
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Cells of corona radiata
Perivitelline space
 
Figure 2.2 Illustration of an ovulated cumulus oocyte complex (COC).  The oocyte is encased by 
a gelatinous matrix and granulosa cells of the cumulus oophorus.  Adapted from Schillo [33].   
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 vivo or in vitro derived).  The mechanisms underlying cryoinjuries are yet to be fully 
understood.  Until more insight is gained, improvements in oocyte cryopreservation will be 
difficult [5].        
 
II. OOCYTE CRYOPRESERVATION 
 
2.3 History 
 
The cryopreservation of mammalian oocytes has a more recent and far less successful history 
than spermatozoa and embryos.  One of the first investigations into the survival of unfertilized 
mouse oocytes during cooling and warming was in 1958 [34].  Around 1975, investigation into 
the fundamental cryobiology of mouse oocytes led to the first report of successful IVF and live 
offspring from cryopreserved mouse oocytes [35-37].  Although Walter Stiles first suggested 
vitrification as a cryopreservation strategy in 1930, it was not until the late 1980’s that ultra-rapid 
cooling was used for mouse embryos, which showed promising results when later applied to 
oocytes [38].  In recent years, there has been increasing interest in the preservation of oocytes 
from several mammalian species and occasional reports of success have been published in 
humans [39], bovine [40] and equine [41].  However, there is yet to be a comprehensive 
understanding of oocyte cryobiology and low fertilization rates need to be resolved before oocyte 
cryopreservation can be routinely applied.     
 
2.4 Principles 
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Cryopreservation involves freezing cells or whole tissues by exposure to sub-zero temperature (-
196 ºC)  in liquid nitrogen (LN2) [23].  At such a low temperature, biological activity is 
effectively stopped and the cells viability and functional state may be preserved for centuries 
[42].  However, several physical stresses can kill cells at these low temperatures.  Intracellular 
ice formation is one the largest contributors to cell death; therefore, freezing protocols use a 
combination of dehydration, freezing point depression, supercooling and intracellular 
vitrification in an attempt to avoid cell damage [43].  However, the removal of excessive water 
results in cell injury and death through the effect of the highly concentrated intracellular 
environment on membranes, referred as the “solution effect” [44].     
 
It is important to consider the nature and concentration of the cryoprotectant when 
cryopreserving germplasm in any cryopreservation protocol.  Cryoprotectants such as dimethyl 
sulfoxide (DMSO), ethylene glycol (EG) or glycerol alone or in combination protect the cells 
and tissues from freezing damage [5].  Moreover, the cooling rate and freezing method are also 
important factors to consider in preventing cryoinjuries of cells. Slow freezing, using a 
controlled freezing curve is commonly used for cell cryopreservation; however, vitrification, 
which uses an ultra rapid freezing velocity and high concentration of cryoprotectants, is gaining 
popularity due to its promising success rates in certain species [5].   
 
2.5 Cryoinjuries 
 
During cryopreservation, the extent of injury incurred in cells largely depends on the size and 
shape of the cell, the permeability of the cell membranes and the quality (grade) of the cell.  
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However, these factors vary between species, developmental stage and origin [45].  Although 
offspring have been born using frozen-thawed oocytes from various species, the ability to 
support embryo development following cryopreservation procedures is low.  This may be 
attributed to the susceptibility of oocytes to damage during cooling and/or freezing and 
subsequent thawing because of their complex structure.  Unfertilized mammalian oocytes are 
much larger than the blastomeres of an early embryo and therefore have a small surface to 
volume ratio [30].  This makes dehydration and penetration of cryoprotectants difficult to 
achieve, which contributes to the difficulty in cryopreservation.  Moreover, the plasma 
membranes of oocytes differ drastically from those of embryos.  Following fertilization, there is 
a rise in intracellular free calcium, which modifies the ionic strength and membrane potential of 
the plasma membrane [46].  During embryo development, the submembranous polymerized 
filamentous actin concentration increases and its conformation changes.  This facilitates the 
permeation of water and cryoprotectants that promotes dehydration and reduces intracellular ice 
crystal formation during cryopreservation techniques.  Additionally, the greater strength of 
embryos’ cell membrane increases the osmotic tolerance during thawing and allows embryos to 
withstand freezing and thawing better than oocytes [30].   
 
Freezing immature, in vitro matured or ovulated oocytes often results in morphological and 
functional damage.  Although the specific molecular pathways disrupted during freezing are not 
well understood, many ultrastructural elements that are critical to maintenance and development 
are damaged [47].  Post-thawed oocytes often exhibit zona pellucida or cytoplasmic membrane 
fractures.  Cooling oocytes from approximately 37 ºC to 20 ºC or below can result in various 
cytoskeletal and chromosomal modifications but in some cases oocytes have the surprising 
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ability to fully or partially repair themselves [10, 45].  The major adverse effects of freezing 
procedures are due to ice crystal formation, osmotic injury, toxic effects of cryoprotectants, 
concentrated intracellular electrolytes, chilling injury, zona fracture and alterations of 
intracellular organelles, cytoskeleton and cell to cell contacts [8, 48].  Strategies to overcome 
these issues involve reducing container volumes, increasing the thermal gradient, altering the cell 
surface to volume ratio and the addition of substances such as antifreeze proteins, sugars or anti-
oxidants that stabilize the membrane during cooling and increase cryotolerance [5, 6].         
 
The developmental stage of oocytes at the time of cryopreservation is thought to affect the cell’s 
cryobiological properties.  Oocytes collected from slaughterhouse-derived ovaries are at the 
germinal vesicle (GV) stage, at which time the genetic material is contained within the nucleus.  
The oocyte nucleus is comprised of a nuclear envelope as well as nuclear material such as 
chromatin and the nucleolus.  Reports have shown that freezing immature oocytes is ideal as 
there is no meiotic spindle present and the genetic material is confined within the nucleus; 
however, immature oocytes are thought to be more sensitive to anisotonic stress and have lower 
cell membrane stability than MII stage oocytes [6, 49-51].  Cooling immature oocytes below 4 
ºC reduces the formation of normal meiotic spindles and fertilization.  Additionally, it has been 
hypothesized that immature oocyte cryopreservation may compromise the structural integrity of 
the nuclear envelope, subsequently influencing deoxyribonucleic acid (DNA) replication, 
transcription and cell function; however, the nucleus does have the ability to reassemble 
following warming [52, 53].  Although a study using time lapse photography on 
vitrified/warmed oocytes observed that the number of nucleoli returned to a normal state 
following warming and rehydration, in some cases nucleolar bodies were observed in the 
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cytoplasm.  However, whether intracellular nucleoli localization influences subsequent function 
and development is still unknown [52].    
 
The success of immature oocyte cryopreservation largely depends on the ability to preserve the 
structural and functional integrity of the entire COC.  Damage to the cumulus cells surrounding 
the oocyte is also thought to affect the success of immature oocyte cryopreservation.  The gap 
junctions between oocytes and cumulus cells play an important role in the maturation process by 
providing nutritive substances that have a supportive role during IVF [10].  It has been 
demonstrated that GV stage oocytes stripped of cumulus cells exhibit deficient nuclear and 
cytoplasmic maturation [49, 54, 55].  However, cumulus cells can also be an obstacle to the 
penetration of cryoprotectants [48].   
 
As oocytes mature to the MII stage of maturation, changes occur in the plasma membrane, which 
affect the permeability of water and cryoprotectants.  Once oocytes resume the first meiotic 
division, the nuclear envelope is disintegrated, allowing the nuclear material to mix into the 
cytoplasm [52].  There are modifications in nucleolar organization and the distribution of 
organelles, such as the mitochondria, cytoskeleton and cortical granules, which may also affect 
the outcome of a cryopreservation technique [56].  Additionally, cumulus cells surrounding the 
oocyte are expanded, microfilaments of actin are involved in cell shape modifications and 
movements, and microtubules form the spindle apparatus [10].  Successful fertilization is highly 
dependent on the maintenance of the structural and functional integrity of COC components.  
Exposing mature oocytes to cryoprotectants and low temperatures can result in damage to the 
meiotic spindle, actin filaments, chromosomal dispersal and microtubule depolymerization [10, 
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57].  Abnormalities of the spindle have been shown to be directly correlated with loss of 
fertilization and developmental abilities as they are crucial for completion of meiosis, second 
polar body formation, migration of the pronuclei and formation of the first mitotic spindle [58] 
 
The microtubule, which is a component of the spindle, is a cylindrical bundle, comprised of 13 
protofilaments (a heterodimer consisting of α and β-tubulin).  Microtubules begin from 
microtubular organizing centers at both poles and anchor chromosomes at the kinetochores [30].  
The chromosomes align at the equatorial plane of the meiotic spindles.  A recent study in porcine 
oocytes found that paclitaxel treatment improved the normality of microtubules by strengthening 
the bond between α and β-tubulin and improved the developmental ability of vitrification of MII 
oocytes [57, 59].       
 
Regardless of the nuclear stage oocytes are cryopreserved at, DNA may be damaged during 
cryopreservation [10]. Cryopreserved oocytes have altered distribution of cortical granules, 
increased polyspermy and zona hardening by premature cortical granule release, which deters the 
entry of sperm and thus fertilization [5, 59-62].  The use of intracytoplasmic sperm injection 
(ICSI) has been suggested to overcome the effects of zona hardening.  In 1995, a study observed 
that using ICSI for frozen thawed oocytes resulted in higher fertilization rates than IVF; 
however, the use of ICSI over IVF requires further investigation [30, 63].   
 
2.6 Criteria to assess the quality of frozen-thawed oocytes 
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There are several different methods used to test the viability and extent of chilling injuries of 
oocytes following cryopreservation.  Typically, the primary criteria used to assess post thaw 
viability of oocytes is the presence/absence of degeneration, cytoplasmic abnormalities 
(characterized by extensive vascuolisation) and zona pellucida fractures [9].  The membrane 
damage can be evaluated using probes to indicate the integrity of the plasma membrane [6].  
Recent studies in humans have examined the meiotic spindle using a polarized microscope 
apparatus, which allows the visualization of the polymerization of the meiotic spindle following 
warming.  However, this technique is difficult in domestic animals due to their high cytoplasmic 
lipid content, which hinders spindle examination.  Therefore, the oocytes of domestic animals are 
typically examined through invasive methods such as fluorescence microscopy and biochemical 
or molecular analyses [9].   
 
Current research is focusing on the development of new oocyte quality and cryotolerance 
evaluation markers.  For example, if the gene expression of the cumulus cells could be correlated 
with oocyte developmental rates, gene expression could be used as a marker for oocyte quality 
before freezing, helping to select the oocytes most suitable for cryopreservation [64].  Moreover, 
determining the volumetric response of matured oocytes to changes in osmolarity during 
preparation for cooling would be another non-invasive response to oocyte evaluation.  This may 
assist in decreasing the toxic and osmotic effects of cryoprotectants on oocytes.  Measuring the 
volumetric responses to increasing cryoprotectants concentrations should permit a precise 
estimate of the ideal timing and concentration of cryoprotectants exposure [9].  Additionally, 
normal vs abnormal gene expression post-thaw could be used to determine which oocytes should 
be inseminated.  Although the viability of frozen-thawed oocytes has been tested using IVF and 
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ICSI, the best way to evaluate the capacity of embryos derived from cryopreserved oocytes is to 
produce viable offspring [65].  Currently there have been live offspring born from cryopreserved 
oocytes in humans [66] and cattle [67].       
     
2.7 Freezing Procedures 
 
The two main methods studied for cryopreservation of oocytes are slow freezing and 
vitrification.  With the exception of cryoprotectant concentration and cooling, these two methods 
differ only slightly with regards to storage, warming and rehydration [45].  Table 2.4 compares 
the two main methods for oocyte and embryo cryopreservation [5]. 
 
Conventional slow freezing was introduced first and is currently the gold standard for 
cryopreservation of embryos.  This method typically involves the use of a single cryoprotectant 
in low concentrations (approximately 1 to 2 M) to minimize chemical and osmotic toxicity and 
attempts to maintain a balance between the various factors that influence cell damage [5].  
During the controlled cooling rate, solution is exchanged between the extracellular and 
intracellular fluids without serious osmotic effects [45].  However, during slow cooling, 
extracellular water precipitates as ice, resulting in ice crystal formation.  Slow freezing gives 
acceptable results for oocytes of species that are not sensitive to chilling such as the cat [68, 69], 
human [39] and mouse [70].  However, bovine and porcine oocytes are more sensitive to chilling 
and yields poor results following slow cooling [6].    
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Many plant and animal species located in Polar Regions, where temperatures can fluctuate 
between -50 °C and +20 °C, survive winter by dehydrating and remaining in a completely 
vitreous state.  Therefore, the pursuit of vitrification in the laboratory can be reassured by its 
success in nature.  The physical definition of vitrification is the glass like solidification of 
solutions at low temperatures, without the formation of intracellular ice crystals.   
 
During this method of cryopreservation, ice crystal formation is prevented due to the viscosity of 
the highly concentrated combination of cryoprotectants (approximately 7 to 8 M) used in 
vitrification solutions that makes water solidify but not expand [48].  Cells undergoing 
vitrification are frozen at an extremely rapid cooling rate and often undergo fewer physiological 
detrimental effects compared with slow freezing [11].  Although, some transitional and very 
short freezing of the solutions can occur during warming following vitrification, this is generally 
harmless to the oocyte.  The disadvantage of using such high concentrations of cryoprotectants is 
the toxicity to the cells.  As a result, oocytes can only be exposed to a minimal volume of  
vitrification solution for a very short time, i.e., <1 min [5].  Extensive research in the past 20 
years has resulted in new approaches which have created an acceptable balance between the 
positive and negative effects of vitrification.  The ultra-rapid cooling rates have allowed 
decreased cryoprotectant concentrations and made vitrification an extremely competitive 
alternative to conventional slow freezing [45]. Presently, vitrification is a popular method for 
cryopreservation of many different cell types, tissues and organs; however, the extent of 
cryoinjuries and developmental rates are highly variable depending on the species [5, 10].     
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Table 2.4 Oocyte and embryo cryopreservation methods. Adapted from Pereira and Marques, 
2008 [5]. 
Freezing procedures 
Conventional slow-freezing method Vitrification 
1.  Standard 0.25 mL straws 1.  Several devices for loading embryos and 
oocytes (conventional straws, open pulled 
straw, cryoloop, cryoleaf, cryotop) 
2.  Low cryoprotectant concentration 2.  High cryoprotectant concentration/ reduced 
volume and time within vitrification solution 
3.  Seeding at -5 to -7 °C, controlled slow 
cooling (0.1 to 1 °C/min) 
3.  Ultra-rapid cooling rates (-2500 °C/min or 
20000 °C/min using open pulled straw and 
cryoloop) 
4.  Plunging at -30 to -70 °C and storage in 
liquid nitrogen (-196 °C) 
4.  Plunging into liquid nitrogen (-196 °C) 
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 Despite the fact that slow freezing is the most widely used cryopreservation technique, 
vitrification is a viable and promising alternative that is becoming increasingly attractive to the 
commercial sector.  Many reports comparing conventional embryo slow freezing and 
vitrification have reported either equal or improved in vitro or in vivo survival rates after 
vitrification [71, 72].  Vitrification of oocytes and embryos has been tested in several species 
with good results, does not require costly coolers or special skill and can be performed fairly 
quickly [48, 73-75].  It has been suggested that with time, conventional slow freezing will be 
replaced entirely by vitrification techniques [45].      
 
2.8 Cryoprotectants 
 
Cryopreservation strategies are based on two main principles: cryoprotectants and cooling-
warming rates [45].  Because water is not very viscous, it can only be vitrified by extremely 
rapid cooling of a small sample or using high concentrations of cryoprotectants [44]. 
Cryoprotectants such as glycerol, DMSO and EG are small molecules that penetrate cells and 
limit the amount of intracellular and extracellular water that converts into ice during cooling. 
However, cells do have a biological limit to tolerate the concentration of cryoprotectants.  It is 
imperative to maximize the cooling rate while minimizing the concentration of cryoprotectants 
during vitrification [44]. 
      
Cryoprotective solutions are typically prepared in buffered media (e.g. TCM-199) with a stable 
pH between 7.2 and 7.4 [76].  Cryoprotectants are compounds used to achieve cellular 
dehydration and avoid intracellular ice crystal formation upon freezing.  Typically, combinations 
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of permeating and non-permeating cryoprotectants are used.  Low molecular weight permeating 
cryoprotectants such as glycerol, EG and DMSO enter the cell, form hydrogen bonds with 
intracellular water molecules and lower the freezing temperature, preventing crystallization.  
Low molecular weight non-permeating cryoprotectants such as sucrose, glucose, trehalose and 
fructose remain extracellular and draw free water out of the cell by osmosis, resulting in 
intracellular dehydration [5]. The addition of sugars to an EG based media can strongly influence 
the vitrification properties of the solution and assist in stabilizing membrane structures [77].  
Disaccharides act as osmotic buffers to reduce osmotic shock and the toxicity of EG by 
decreasing the concentration required to achieve successful cryopreservation [44].   
   
High molecular weight non-permeating polymers or macromolecules are commonly used to 
reduce the amount of intracellular cryoprotectants necessary for vitrification, reducing the 
toxicity of the solution.  Polymers have been shown to protect against zona pellucida cracking 
[5].  The majority of solutions used for oocyte vitrification contain a macromolecular component 
of fetal calf serum (CS) or bovine serum albumin (BSA).  Other macromolecules used in 
vitrification solutions include polyethylene glycol, polyvinylpyrrolidone, Ficoll and polyvinyl 
alcohol [5].           
 
The addition of non-permeating polymers, a combination of more than one cryoprotectant and 
their stepwise exposure minimizes the toxic effects of cryoprotectants on cells.  Additionally, it 
has been shown that adding cells to a lower concentration of EG before transferring them to a 
higher concentration disaccharide mixture can reduce the toxic effect of cryoprotectants [44].  
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2.9 Cooling Rate 
 
Although a practical limit to attainable cooling speeds exist, it has been reported that a cooling 
rate of approximately 2500 ºC/min can achieve a vitrified state [76].  However, using a suitable 
carrier system such as the open pulled straw (OPS), a cooling rate of 20 000 ºC/min can be 
achieved [73].  The main reasons for increasing cooling and warming rates are to avoid ice 
crystal formation and to decrease the concentration of cryoprotectant solutions [44].  By passing 
cells through the critical temperature zone (15 to -5 ºC) quickly, water is able to move out of the 
cells and freeze extracellularly [10].  This prevents chilling injury to the intracellular lipid 
droplets, lipid containing membranes and the cytoskeleton [48].     
 
As cells are immersed in LN2, extensive boiling results from the warming of LN2.  Consequently, 
evaporation occurs and a vapor coat surrounds the cells and creates an insulating layer that 
decreases the temperature transfer and cooling rate.  Avoiding LN2 vapor formation through the 
application of negative pressure with a vacuum can produce a slush state (SN2) that decreases the 
internal temperature and as a result, the cooling rate can be increased [78].  Minimizing the 
volume surrounding the cell, and establishing direct contact between the cryoprotectant and the 
LN2 can also assist in increasing the cooling and warming rates during vitrification of cells [44].  
However, techniques based on the direct contact of LN2 and the medium containing the oocytes 
may be a source of contamination.  These risks can be minimized by using sterile LN2 for 
cooling, then wrapping the oocytes in a hermetic container before storage; however, this 
procedure may be too complex for everyday application [48].      
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The development of special carriers such as the open-pulled straw [79], microdrops [80], 
cryoloop [81], flexipet-denuding pipette [82], electron microscopic copper grids [83], hemistraw 
system [84], small nylon coils [85], nylon mesh [86] and cryotops [87] have helped to achieve 
higher cooling rates while permitting the use of less toxic and less concentrated solutions [10]. 
These carriers shorten the time of exposure with the final cryoprotectant before cooling and after 
warming and the small volume of solution prevents heterogeneous ice formation [48].   
 
III. VITRIFICATION OF OOCYTES 
 
Over the years there has been considerable effort focused on reducing the time of freezing 
procedures and eliminating the need for programmable cell freezers required during conventional 
slow freezing.  Moreover, equilibrium freezing may not be the most advantageous method to 
cryopreserve oocytes as they are damaged due to long exposure to temperatures near 0 ºC [10].  
Vitrification is the alternative method of cryopreservation which uses an ultra rapid cooling rate, 
eliminating the need for programmable freezing equipment.  Furthermore, the vitrification 
technique uses a high cryoprotectant concentration which avoids water precipitation, preventing 
intracellular ice crystal formation [5].  In the last several years, almost all advancements in 
oocyte cryopreservation have been made using vitrification techniques and their use for oocyte 
and embryo cryopreservation will undoubtedly increase in the future [45].       
 
In 1985, vitrification of mouse embryos emerged as an alternative approach to traditional slow 
freezing methods [38].  However, the first successful mouse embryo vitrification was 
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documented in 1993 [88].  Bovine oocytes were able to develop to the blastocyst stage following 
high cooling rates [89] and pregnancies have been achieved following vitrification of human 
oocytes [90, 91].  Since this time, there has been a dramatic increase in the number of 
publications concerning vitrification.     
 
Many variables in the vitrification process exist that can profoundly influence the survival rate of 
oocytes.  The extent of injury and the differences in survival and developmental rates are 
variable depending on the species, developmental stage and origin [5].  The type and 
concentration of the cryoprotectant, the temperature of the vitrification solution at the time of 
cell exposure and the duration of exposure to the final cryoprotectant before plunging in LN2 are 
all important factors to consider in order to improve survival rates.  The exposure time of oocytes 
and embryos to cryoprotectants may be shortened, or they are often pre-equilibrated in a 
vitrification solution containing a lower concentration of permeating cryoprotectants, to avoid 
any anticipated toxic shock resulting from exposure to higher concentrations of cryoprotectants 
in final vitrification solution [92-94]. However, it is not yet clear whether a pre-exposure to 
lower concentrations of vitrification is necessary and if so, what is the optimal time for such 
exposure.  During warming, the main biophysical factor causing cellular disruption is osmotic 
injury, which can occur during the removal of penetrating cryoprotectants from the cell.  The 
ideal time for oocytes to be suspended in warming solution is still uncertain.  If the time is 
insufficient, osmotic injury can occur, which is especially important given that cryopreserved 
cells are much more sensitive than non-frozen cells [95].   
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Moreover, the type of cryodevice used for vitrification influences the cooling rate and size of the 
vapor coat.  Oocytes from humans [96-98], pigs [99], horses [100], sheep [81, 101], cattle [102] 
and buffalo [103, 104] have developed in vitro following cryopreservation using cryotop.  
Although results are inconsistent, meiotic stage is also thought to contribute to oocyte 
survivability following cryopreservation [50, 105-109].  The ideal strategy to improve the 
success of vitrification includes increasing the speed of thermal conduction and decreasing the 
concentration of cryoprotectants [44].             
 
2.10 Humans 
 
Long term storage of oocytes from women who are late in their reproductive life, have hereditary 
diseases, abnormal oocytes, wish to delay childbirth until later in their reproductive life or who 
are in danger of losing ovarian function due to pelvic disease, surgery , chemo- and/or 
radiotherapy are the most important reasons to cryopreserve human oocytes [5, 56].  Oocyte 
cryopreservation could assist patients who have a history of difficulty with oocyte collection.  
Furthermore, women undergoing IVF could freeze excess oocytes and avert repeated ovarian 
stimulation and oocyte retrieval or use them for oocyte donation.  This technique has particular 
implications for allowing sufficient time for screening donors to prevent disease transmission 
and in countries that permit the donation of oocytes but not embryos to infertile couples [30, 56].  
Although ovarian tissue cryopreservation has shown some success, ovaries are highly sensitive 
to cytotoxic treatments.  Additionally, there is often loss of endocrine and gametogenic function 
following ovarian tissue cryopreservation.  In recent years there has been considerable effort 
focused on preserving oocytes in order to avoid the ethical, legal and religious problems raised 
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by freezing embryos [110].    Currently, slow cooling techniques are widely used, although 
vitrification is increasing in popularity.   
 
Slow cooling using rapid thawing has shown promising improvements in the rate of clinical 
pregnancies per thawed oocyte and clinical pregnancies per transfer [111].  However, results are 
still not comparable to those obtained during IVF using non-frozen oocytes.  Currently it is 
unclear why oocytes can survive slow cooling, fertilize and cleave with high rates but later 
become compromised during implantation.  There is undoubtedly damage other than the 
cytoskeletal apparatus that is compromising the developmental performance [110].     
 
Vitrification has also been used to cryopreserve both immature and mature human oocytes as it 
avoids cellular lesions caused by ice crystallization that often occurs during slow cooling.  
However, during the vitrification technique, the sample is in direct contact with LN2, increasing 
the risk for microorganism contamination.  Currently cryopreservation of mature, MII human 
oocytes is challenging.  Collection of mature oocytes requires approximately one month’s 
induction, often making it unfeasible in cancer treatments.  The alternative is to cryopreserve 
immature oocytes; however, in vitro maturation is required and is currently unreliable [110].         
 
Although results have improved over the last several years, oocyte cryopreservation results are 
still not comparable with those for frozen embryos and cannot yet be applied to create donor 
oocyte banks [110].  The use of ICSI has helped conquer premature cortical granule release; 
however its use needs to be investigated further [30].  The current results are encouraging but the 
technique still needs to be assessed, particularly with regards to the high concentration of 
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cryoprotectant required and the contamination risk involved in exposing the samples directly to 
LN2 [110].  Improving the cryopreservation technique would solve ethical issues surrounding 
embryo cryopreservation, egg donation and preservation of fertility for cancer patients and 
women who wish to extend their child bearing life.  Furthermore, human oocyte 
cryopreservation would solve physiological problems and help maintain excess oocytes 
generated following superovulation treatment [6].      
 
2.11 Cattle 
 
Although the cryopreservation of bovine oocytes remains a challenge, some of the most 
encouraging results among domestic animals have been obtained in the bovine, where offspring 
have been born from immature and mature vitrified oocytes following IVF and culture [112, 
113].  Vajta [1998] reported a 25% blastocyst rate on day 8 following vitrification using OPS, 
thawing, IVF and culture in vitro.  Although bovine oocytes are much more cryostable than 
porcine oocytes due to less lipid contents and intracellular lipid droplets and vesicles, they are 
much more difficult to successfully cryopreserve than bovine embryos [114].  GV stage bovine 
oocytes have homogenous lipid droplets that show little change following cooling; however their 
large size and low surface to volume ratio makes it difficult for water and cryoprotectants to 
move across the plasma membrane [115].     
 
Currently one of the main issues associated with cryopreservation of bovine oocytes is the 
source.  The majority of oocytes are collected from slaughterhouse derived oocytes, which 
presents a problem because oocytes are derived from follicles of different sizes, and thus 
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different stages of development, which tolerate freezing differently.  The other issue with this 
source is the fact that subsequent maturation occurs in vitro as opposed to in vivo, which also 
influences the freezing tolerance of the oocytes [10].   
 
Good quality bovine oocytes should be used to obtain higher blastocyst formation and healthy 
offspring following vitrification.  It has been shown that oocytes matured in vivo demonstrate a 
significantly higher maturation rate and blastocyst formation than those matured in vitro [116, 
117].  Oocytes obtained from large growing (subordinate) follicles that are not in the presence of 
a dominant follicle and have large enough diameters to be considered competent also assists in 
improving cryopreservation rates of bovine oocytes.  Moreover, it has been shown that partially 
removing cumulus cells several hours after the onset of in vitro maturation (IVM) may facilitate 
improved cryoprotectant penetration while still maintaining supportive and nutritive roles [10].                
 
Although modifying cryopreservation methods to fit the cell type being cryopreserved may be 
preferable, modifying cells to fit the cryopreservation procedure has also been proposed to 
improve survival rates [115].  One study examined the possibility of transferring cholesterol to 
bovine oocytes membranes and found a significant (P<0.05) improvement in cleavage rates and 
development to the 8 cell stage relative to the control (55% vs 41%) [118].  Another study which 
centrifuged mature bovine oocytes in order to partially remove cytoplasmic lipid droplets prior to 
vitrification found the frequency of polyspermy was reduced in those surviving freeze-thawing 
compared to the surviving control oocytes [119].  Modifying the lipid content, removing serum 
albumin from media and the addition of a membrane stabilizer such as trehalose to the cytoplasm 
may all be areas worth investigating further [115].    
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2.12 Other farm animals 
 
The banking of oocytes from non-human species used for laboratory experiments could be used 
to preserve specific strains, without the high cost associated with continuous breeding [56].   In 
farm animals, oocyte cryopreservation allows female’s genetic material to be stored unfertilized 
until a suitable mate is selected [5].  Although offspring have been produced after the transfer of 
embryos from frozen-thawed oocytes in several species [39, 120], the overall success rate has 
been low, primarily due to the decreased rate of fertilization following freezing and thawing [76].         
 
Similarly to embryos, porcine oocytes are highly sensitive to low temperatures. Consequently 
viable piglets have not yet been born from cryopreserved oocytes, despite blastocyst 
development following cryopreservation of MII stage oocytes [57, 99].  The meiotic spindle of 
porcine oocytes is extremely sensitive to cryopreservation, resulting in impaired development at 
meiosis II [30]. However, the main cause of poor survival following vitrification can be 
attributed to the high intracellular lipid content within porcine oocytes.  Porcine GV oocytes 
contain 2.4-fold more lipid droplets than bovine oocytes [121].  Additionally, dark homogenous 
lipid droplets as well as grey ones with electron-lucent streaks change morphologically from 
round to spherical with lucent streaks during cooling [5, 114].  However, it has been 
demonstrated that the removal of cytoplasmic lipid droplets using delipation increases their 
freezing tolerance [122].  A recent study combined the removal of cytoplasmic lipid droplets 
with microtubule stabilization and found vitrified porcine in vitro matured MII stage oocytes 
could develop to the blastocyst stage and maintain the ability to develop into fetuses [57].  
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Furthermore, the use of cholesterol-loaded cyclodextrin to increase the cholesterol content of 
oocyte membranes has improved cryotolerance [115].        
 
In horse, immature oocytes undergo significant damage during controlled freezing.  Less than 
16% reach MII during post thaw maturation, which is less than the 50-80% MII rates typical for 
non-cryopreserved oocytes [123, 124].  Although MII rates are higher in equine oocytes that 
have been vitrified (28-46%), approximately 50% of those oocytes that reach MII exhibit spindle 
abnormalities and poor developmental competence [41, 47, 125].  Much of the damage sustained 
to equine oocytes is on the mitochondria and gap junctions between the oocyte and surrounding 
cumulus-corona radiata cells and these interactions are critical to successful maturation and 
developmental competence [54].    
 
Currently, a limited number of studies have been done on the vitrification of small ruminant 
oocytes, especially in sheep, where poor developmental rates are obtained following immature 
[126, 127] and mature [81] oocyte vitrification.  Poor ovine oocyte cryopreservation has been 
attributed to damage to enzymes such as MAP kinase, which is critical to oocyte maturation and 
subsequent embryo development.  A 2007 study revealed that denudation of immature ovine 
oocytes prior to vitrification increased survival and maturation ability.  However, the process 
also decreased Maturation Promoting Factor (MPF) and Mitogen-Activated Protein Kinase 
(MAPK) concentrations, which influence meiotic and mitotic cell cycle regulation and 
developmental competence [49].  The same study also revealed that vitrification alters the 
functional coupling between oocytes and surrounding cumulus cells which reduces gap junction 
communication.  In addition, there are significant modifications of spindle and chromatin 
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configurations in vitrified immature ovine oocytes.  Current investigations are focusing on the 
factors influencing the ability of vitrified ovine oocytes to undergo IVF and develop further.       
 
Despite recent advancements, the cryopreservation of oocytes of most mammalian species 
remains a challenge due to their complex structure.  Although there have been an increasing 
number of publications regarding vitrification of oocytes, more research is required to further 
elucidate the species-specific mechanisms influencing poor survivability following vitrification.  
Moreover, additional modifications of oocytes to fit the cryopreservation technique may be 
necessary, especially in species whose oocytes have extremely high lipid contents.             
 
IV. CONCLUSIONS 
 
The loss of farm animal genetic diversity is occurring at alarming rates across the globe.  
Traditions, cultural values and safeguarding diversity for an unpredictable future are all driving 
forces for genetic conservation, which is a global responsibility.  Preserving live animals permits 
further evolution of breeds; however, in many cases; in situ conservation strategies are not 
practical or adequate.  Therefore, establishing genetic resource banks to conserve the current 
genetic status would provide a crucial interface between ex situ and in situ conservation 
strategies.   
 
Cryopreservation of oocytes is a crucial step for the conservation of female genetics.  However, 
despite decades of research, oocyte cryopreservation remains a challenge in virtually all species 
due to the complex structure of the oocyte.  Conventional slow freezing commonly leads to 
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intracellular ice crystallization and cell damage, and although vitrification of bovine oocytes is 
being studied increasingly, it is still challenging due to the complex structure of oocytes and 
sensitivity to chilling.  Vitrification is a relatively simple and inexpensive method of 
cryopreserving oocytes; however, despite tireless efforts over the past 20 years, vitrification has 
yet to produce convincing results capable of widespread application.  It is critical that researchers 
achieve more consistent results and establish a “universal” protocol that can be applied for the 
cryopreservation of oocytes at different developmental stages.  The goals of my thesis are to 
establish an efficacious vitrification protocol and increase the ability of vitrified bovine oocytes 
to cleave and subsequently develop into embryos.      
 
V. HYPOTHESES AND OBJECTIVES 
 
• Hypothesis 1: Cryotop is a more efficacious packaging system than 0.25 mL straws for 
vitrification of bovine COCs.   
 
• Objective 1:  Compare nuclear maturation of bovine oocytes in vitro following 
vitrification using two different packaging systems (cryotop vs 0.25 mL straw).  
 
• Hypothesis 2:  Vitrification of immature bovine oocytes with and without equilibration in 
vitrification solution 1 has similar effects on post-warming nuclear maturation.  
 
• Objective 2:  Compare nuclear maturation of bovine oocytes in vitro following 
vitrification using two different equilibration times (0 vs 10 min). 
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• Hypothesis 3:  Vitrification of immature bovine oocytes following an extended 
equilibration time in vitrification solution 1 has no effect on cleavage and subsequent 
embryo development.   
 
• Objective 3:  Compare cleavage and developmental competence of bovine COCs vitrified 
using different equilibration times (0 vs 5 min).   
 
• Hypothesis 4:  As compared to frozen-thawed solutions, vitrification of immature bovine 
oocytes in fresh vitrification solutions result in improved cleavage rates and subsequent 
embryo development.   
 
• Objective 4:  Compare cleavage and developmental competence of bovine COCs vitrified 
using different vitrification solutions (fresh vs frozen). 
 
• Hypothesis 5: Immature (GV stage) bovine oocytes will mature in vitro within 22 h.   
 
• Objective 5:  Validate our in vitro maturation system. 
 
• Hypothesis 6:  Nuclear stage of bovine oocytes at the time of vitrification affects their 
post-warm nuclear maturation in vitro, cleavage ability and developmental competence. 
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• Objective 6: Evaluate nuclear maturation, cleavage and subsequent embryo development 
following vitrification of bovine oocytes at different nuclear stages. 
 
• Hypothesis 7:  Exposure of bovine COCs to cryoprotectant solutions affects their ability 
to become fertilized, cleave and develop into embryos.  The higher concentrations of 
cryoprotectant solutions used in vitrification procedures will have toxic effects on bovine 
COCs, resulting in poor cleavage and embryonic development.   
 
• Objective 7:  Determine the role of cryoprotectant solutions in the observed reduced rates 
of cleavage of vitrified bovine oocytes and subsequent embryo development by studying 
the effect of exposure of bovine COCs to vitrification solutions and vitrification on 
cleavage and blastocyst rates.   
 
• Hypothesis 8:  Warming vitrified COCs for a longer interval will improve the removal of 
intracellular cryoprotectants resulting in higher cleavage and blastocyst production rates.       
 
• Objective 8:  Study the effect of time of exposure of bovine COCs to warming solutions 
(1 vs 5 min) on cleavage and subsequent embryo development. 
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CHAPTER 3: FACTORS AFFECTING NUCLEAR MATURATION, CLEAVAGE, AND 
SUBSEQUENT DEVELOPMENT OF VITRIFIED BOVINE CUMULUS-OOCYTE 
COMPLEXES 
 
3.1 Abstract 
 
The objective of this study was to investigate the effect of equilibration time, vitrification 
solutions and cryodevice on in vitro maturation and cleavage of vitrified bovine oocytes, and 
subsequent embryo development.  Experiment 1 was designed to compare the nuclear maturation 
rate (i.e., to Metaphase II; MII) of immature bovine cumulus oocytes complexes (COCs) vitrified 
using two equilibration time intervals (0 vs 10 min) in vitrification solution 1 [VS1; TCM-199 + 
7.5% ethylene glycol (EG) + 7.5% dimethyl sulfoxide (DMSO) + 20% calf serum (CS)] 
followed by exposure to vitrification solution 2 (VS2; TCM-199 + 15% EG + 15% DMSO + 
17% sucrose + 20% CS) for <1 min and two different cryodevices (cryotop vs 0.25 mL straw).  
The COCs were warmed for 1 min in warming solution (TCM-199 + 17% sucrose + 20% CS).  
The MII rate was higher in the non-vitrified control group than in vitrified groups (61 vs 16%, 
P<0.001). In the vitrified groups, equilibration time in VS1 did not affect MII rate (P=0.964); 
however, MII rate was higher in COCs vitrified on cryotops than in straws (23 vs 9%, P=0.007). 
In Experiment 2, immature bovine COCs were vitrified on cryotops using vitrification solutions 
either prepared fresh or frozen/thawed, and two equilibration times in VS1 (0 vs 5 min).  
Cleavage and blastocyst production rates were higher (P<0.001) in the non-vitrified control 
group than vitrified groups (cleavage rate 93 vs 42% and blastocyst rate 31 vs 0.4%). Cleavage 
rate of COCs vitrified in frozen/thawed solutions with 5 min equilibration was higher (P=0.05)  
 
*This study has been accepted for publication in Theriogenology.   
43 
 
than other treatment groups.  However, the blastocyst rate did not differ (P=0.993) among 
vitrified groups.  In conclusion, the use of cryotops resulted in higher survival rates than 0.25 mL 
straws for the vitrification of bovine COCs.  Furthermore, 5 min equilibration in VS1 resulted in 
higher cleavage rates than no equilibration time.  Compared with non-vitrified controls, the 
vitrification procedure per se seemed to damage bovine COCs, resulting in reduced nuclear 
maturation and embryo development rates.  However, cleavage rates were within acceptable 
limits.     
 
3.2 Introduction 
 
From conservation of animal genetic resources standpoint, the accessibility of frozen semen is 
abundant but it ensures only one half of the animal genetics.  The preservation of the remaining 
half, i.e. female genetics, is quite challenging because oocytes are scarcely available and are 
sensitive to cryopreservation techniques [86].   Developing a reliable method for maintaining the 
viability of mammalian oocytes after long term preservation is important for the conservation of 
female genetics.  
 
Conventional slow freezing method for cryopreservation of oocytes and embryos often causes 
osmotic shock and intracellular ice crystallization, resulting in cell damage [9].  Vitrification is 
an alternate method of cryopreservation in which cells are exposed to high concentrations of 
cryoprotectants and frozen with an ultra-rapid cooling rate, resulting in an ice-crystal free solid 
glass-like structure [5].  Presently, vitrification is a popular method for the cryopreservation of 
bovine embryos [45] due to its simplicity and success rate; however, limited success has been 
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reported on vitrification of cumulus oocyte complexes (COCs) due to their complex structure 
and sensitivity to chilling [10].   
 
During vitrification, cells and tissues are exposed to higher concentrations of cryoprotectants and 
are frozen at ultra-rapid cooling rate [82].  The sudden exposure to high concentrations of 
cryoprotectants is toxic to oocytes [81, 87, 102].  Therefore, the exposure time of oocytes and 
embryos to cryoprotectants is shortened, or they are often pre-equilibrated in a vitrification 
solution 1, “VS1”, which contains a lower concentration of permeating cryoprotectants than 
vitrification solution 2, “VS2” [92-94].  However, it is not yet clear whether pre-exposure to a 
lower concentration of vitrification solution is necessary and if so, what the optimal time for such 
exposure is.  We hypothesized that 1) vitrification of immature bovine oocytes with and without 
equilibration in vitrification solution 1 has similar effects on post-warming nuclear maturation 
and 2) vitrification of immature bovine oocytes following an extended equilibration time in 
vitrification solution 1 has no effect on cleavage and subsequent embryo development.   
 
Several cryodevices have been designed to use the minimum sample volume to achieve ultra-fast 
cooling rate.  These devices include open pulled straw (OPS) [73], cryoloop [128], microdrop 
[113], flexipet-denuding pipette [84, 129], electron microscope copper grid [89], cryotip [130], 
nylon mesh [131] and the hemi-straw system [132].  One such promising and recent device is the 
cryotops, which allows the loading of oocytes or embryos with minimal volume [87, 98].  
Oocytes from humans [97, 98], pigs [99], horses [100], sheep [81], cattle [102] and buffalo [103] 
have been successfully cryopreserved using cryotop.  However, cryotop poses a biosecurity 
threat to the cells, which are exposed directly to liquid nitrogen (LN2).  Therefore, 0.25 mL 
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straws could be a better alternative to avoid possible contamination concerns.  However, the 
cooling velocity in straws is not as rapid as in cryotop [133].  Therefore, we hypothesized that 
cryotop is a more efficacious packaging system than 0.25 mL straws for vitrification of bovine 
COCs.        
 
Although cryopreservation of bovine oocytes is challenging, some of the most encouraging 
results among domestic animals have been obtained in the bovine [40, 112, 134], where 
offspring have been born from vitrified oocytes following in vitro fertilization (IVF) and in vitro 
culture (IVC) [135].  In 1998, Vajta [73] reported a 25% blastocyst rate on day 8 following 
vitrification using the OPS method.  Immature, germinal vesicle (GV) stage bovine oocytes have 
homogenous lipid droplets that shows little change following cooling.  However the large size 
and low surface: volume ratio of oocytes makes it difficult for water and cryoprotectants to move 
across the plasma membrane [115].  To date, there is no standardized procedure for 
cryopreservation of bovine oocytes.        
 
Generally, the vitrification solutions (VS1 and VS2) are prepared and stored in a freezer (-20 °C) 
to avoid batch-to-batch difference and improve convenience. Based on the poor nuclear 
maturation in vitrified oocytes in Experiment 1, we hypothesized that repeated freezing and 
thawing may change the vitrifiability of cryoprotectants in vitrification solutions. 
 
The objective of this study was to investigate the effect of cryodevice, and equilibration time on 
in vitro maturation (IVM), cleavage and embryo development of vitrified bovine oocytes.  In the 
first study, the effects of equilibration in VS1 (0 vs 10 min) and cryodevice (cryotop vs 0.25 mL 
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straw) on the nuclear maturation of vitrified bovine COCs were examined.  In the second study, 
the effects of equilibration in VS1 (0 vs 5 min) and vitrification solutions (fresh vs frozen-
warmed) on cleavage and subsequent embryo development of vitrified bovine COCs were 
examined.    
 
3.3 Materials and methods 
 
3.3.1 Chemicals and supplies  
  
Dulbecco’s phosphate buffered saline (DPBS), Ca-Mg free DPBS, newborn calf serum (CS), 
TCM-199 and MEM non-essential amino acids were purchased from Invitrogen Inc. (Burlington, 
ON, Canada).  Lutropin (LH) and Folltropin (FSH) were supplied by Bioniche Animal Health, 
Inc (Belleville, ON, Canada).  All other chemicals and reagents were purchased from Sigma-
Aldrich (Oakville, ON, Canada), unless otherwise stated.     
 
3.3.2 COCs collection and initial processing 
 
Bovine ovaries were collected from a slaughterhouse and transported to the laboratory at 
approximately 25 °C within 6 h.  Ovaries were washed in normal saline and extra ovarian tissues 
were removed.  Follicles <8mm in diameter were aspirated using a 18-gauge needle attached to a 
5 mL syringe containing approximately 1.0 mL of wash medium consisting of DPBS 
supplemented with 5% CS (v/v).  The aspirated follicular fluid was pooled in 50 mL conical 
tubes and allowed to settle.  The COCs were searched under a stereomicroscope, washed (3x) in 
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DPBS + 5% CS and COCs with more than three layers of cumulus cells and uniform cytoplasm 
(Grade One) were selected for further processing [136].   
 
3.3.3 Vitrification and warming procedures  
  
The COCs were vitrified by equilibrating in VS1 (TCM-199 + 7.5% ethylene glycol (EG; v/v) + 
7.5% dimethyl sulfoxide (DMSO; v/v) + 20% CS) for 10 min at 37 °C.  After equilibration, 
COCs were transferred through three 20 µL-drops of VS2 [TCM-199 + 15% EG + 15% DMSO 
+ 20% CS + 17.1% sucrose (w/v)] at 37 °C for a total exposure time of < 1 min.  Groups of five 
equilibrated COCs were loaded in 0.25 mL French straw (IMV, Woodstock, ON, Canada) as 
shown in Figure 3.1, or placed on cryotop (Kitazato Supply Co., Fujinomiya, Japan) as shown in 
Figure 3.2, and directly plunged in LN2.  For warming of COCs, cryotop was individually 
immersed in 37 °C warming solution consisting of TCM-199 + 20% CS and 17.1% sucrose for 1 
min. Straws were individually immersed in 15 mL falcon tube containing 37 °C warming 
solution for 1 min.  The straw contents were emptied in 30 mm Petri dish containing warming 
solution.  After warming, COCs were washed (3x) in DPBS + 5% CS.  
 
3.3.4 In vitro maturation, fertilization and culture 
 
The COCs were washed (3x) in maturation media (TCM-199 supplemented with 5% CS, 5 
µg/mL LH, 0.5 µg/mL FSH and 0.05 µg/mL gentamicin).  For IVM, groups of 20 COCs were 
placed in 100 µL droplets of maturation media, under mineral oil and incubated for 22 h at 38.5 
°C, 5% CO2 in air and high humidity.  For IVF, frozen-warmed pooled semen from several bulls  
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Figure 3.1 Example of loading 0.25 mL straws for vitrification of cumulus oocyte complexes 
(COCs).  Straw contains columns of warming solution, air, and five COCs in VS2 solution.    
 
Cotton plug Warming solution 
Air 
COCs in VS2 
Warming solution Air 
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Figure 3.2 Example of cryotop for vitrification of cumulus oocyte complexes (COCs).  Cryotop 
contains a lid, five COCs in VS2 on a thin plastic sheath and a handle.    
50 
 
was washed through a Percoll gradient (45% and 90%) [137].  After washing, sperm were added 
to Brackett-Oliphant (BO) fertilization media [138] to a final concentration of 3 x 106/mL.  
Following 22 h of IVM, groups of 20 oocytes were washed (3x) in BO supplemented with 10% 
BSA (w/v) and added to 100 µL droplets of sperm in BO, under mineral oil.  After 18 h of co-
incubation with sperm at 38.5 ºC, 5% CO2 in air and high humidity, cumulus cells and sperm 
attached to oocytes were mechanically removed via pipetting.  The presumptive zygotes were 
washed (3x) through IVC medium CR1aa with 5% CS, 2% BME essential amino acids (v/v), 1% 
MEM nonessential amino acids (v/v), 1% L-Glutamic acid (v/v), 0.3% BSA and 0.05 µg/mL 
gentamicin, transferred in 100µL IVC droplets under mineral oil and incubated at 38.5 ºC under 
5% CO2, 90% N2, 5% O2 and high humidity.  After 48 h in culture, cleavage rate was recorded 
and embryo culture was continued in the same drops.  Blastocyst rate was recorded on Days 7, 8 
and 9 (Day 0= day of IVF).    
 
3.3.5 Oocyte staining 
  
Following 22 h in vitro maturation, COCs were completely denuded with 0.3% hyaluronidase in 
Ca-Mg free DPBS and stained by aceto-orcein method [139] to examine the meiotic status of the 
oocyte. Briefly, the oocytes were then mounted on microscope glass slide under coverslip (using 
paraffin-vaseline supports at corners of the coverslip to prevent oocyte rupture) and fixed in 
ethanol: acetic acid (3:1) for 24 h.  The oocytes were stained with 1% orcein (w/v) in 45% acetic 
acid (v/v) for 20 min and then a minimal amount of differentiate solution (20% glycerol (v/v) 
and 20% acetic acid) was gently run between the slide and cover slip.  The stages of nuclear 
maturation were determined as previously described [140].  Oocytes were evaluated for the stage 
51 
 
of nuclear maturation as germinal vesicle (GV), germinal vesicle breakdown (GVBD), 
metaphase I (MI) or metaphase II (MII) as shown in Figure 3.3.  For data analysis, GV stage 
oocyte were considered immature, MII oocytes were considered fully mature, and GVBD and 
MI stages were pooled and designated as intermediate (INT) stages.   
 
3.3.6 Experimental design  
 
3.3.6.1 Experiment 1: Effect of equilibration time and cryodevice on nuclear maturation 
 
The objective of this 2 x 2 factorial design study was to examine the effect of cryodevice and 
equilibration time on nuclear maturation of vitrified bovine COCs. In one of the treatment 
groups, COCs were vitrified by equilibrating in VS1 and VS2.  In the other treatment group, 
equilibration in VS1 was skipped and COCs were directly exposed to VS2 for 1 min.  Groups of 
five equilibrated or non- equilibrated COCs were either loaded in 0.25 mL straw (10 min-straw 
and 0 min-straw groups) by aspiration or placed on cryotop (10 min-cryotop and 0 min-cryotop 
groups) and directly plunged in LN2.  Both, non-vitrified (control group) and vitrified COCs 
were cultured for IVM as described above.  All COCs were stained with aceto-orcein method for 
nuclear evaluation following 22 h culture as mentioned above.  This experiment was repeated 
four times on different dates (replicates).  
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Figure 3.3 Classification of bovine oocytes using aceto-orcein staining method: Germinal 
Vesicle (GV; A), Germinal Vesicle Breakdown (GVBD; B), Metaphase I (MI; C) and Metaphase 
II (MII; D).  Magnification 100 x.   
C D 
A B 
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3.3.6.2 Experiment 2: Effect of vitrification solutions and equilibration time on cleavage and 
embryo development   
 
The objective of this 2 x 2 factorial design experiment was to examine the effect of vitrification 
solutions and equilibration time on cleavage and embryo development.  The COCs were 
collected, vitrified, warmed and in vitro matured as mentioned above. Collected COCs were 
randomly divided into two groups.  In treatment groups, COCs were exposed to VS1, VS2 and 
warming solutions either freshly prepared on the day of experiment (fresh solutions group) or 
frozen at -20 ºC (frozen solutions group).  Fresh and frozen VS1, VS2 and warming solutions 
were kept at 37 °C for at least 1 h before use.  The COCs in each solutions group were further 
randomly assigned to equilibration and non-equilibration groups.  In equilibration group, COCs 
were first equilibrated in VS1 for 5 min at 37 °C and then exposed to VS2 at 37 °C (5 min-fresh 
solutions and 5 min-frozen solutions groups).  In non-equilibration group, COCs were directly 
exposed to VS2 without equilibration in VS1 (0 min-fresh solutions and 0 min-frozen solutions 
groups).  Five of each kind of COCs were placed on each cryotop and plunged in LN2.  The 
COCs in fresh solutions were warmed in freshly prepared warming solution and COCs in frozen 
solutions were warmed in frozen-warmed warming solution, at 37 °C for 1 min.  Both, non-
vitrified (control) and vitrified COCs were cultured for IVM as described above.  Following 22 h 
of culture, all groups underwent in vitro fertilization and culture as mentioned above.  This 
experiment was repeated five times on different dates (replicates). 
 
3.3.7 Statistical analysis 
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In Experiment 1, the unclassified and degenerated oocytes were excluded from statistical 
analysis.  In Experiment 2, all the vitrified-warmed oocytes were subjected to IVF and IVC, and 
included in statistical analysis.  Data were analyzed using Proc Glimmix in SAS® Enterprise 
Guide 4.2 [141]. For both Experiment 1 and 2, two analyses were performed. First analysis 
compared the non-vitrified control group with combined vitrified groups. Second and final 
analysis included only the vitrified groups and was performed using a 2x2 factorial randomized 
complete block design modeling binary distribution (for yes/no response variable). Main effects 
and interactions were considered statistically different at P-value < 0.05. Replicate number (1 to 
4), cryodevice (1=straw, 2=cryotop), equilibration time (1=no equilibration in VS1, 2=10 min 
equilibration in VS1) and binomial response (MII=1, No MII=2) were recorded for each oocyte.  
Syntax of SAS program included: Proc glimmix method=quad; class replicate cryodevice 
equilibration; model MII (event=”1”) =cryodevice|equilibration /dist=bin link=logit; random 
intercept/ subject=replicate; run. If the P-value for cryodevice*equilibration interaction term 
from Type III sum of squares was < 0.05, then lsmeans cryodevice and equilibration / diff lines 
ilink or adjust= tukey; was added to the syntax for separation of group means.    
 
3.4 Results 
 
3.4.1 Experiment 1: Effect of equilibration time and cryodevice on nuclear maturation 
  
A total of 64 oocytes were used in non-vitrified control group.  After maturation, 10 (16%) 
oocytes were unclassified and there were no degenerated oocytes in this group.  Of the total 260 
oocytes in the vitrified groups, 32 (12%) were unclassified and 5 (2%) were degenerated.  In 
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vitro maturation rates of bovine oocytes in control and vitrified oocytes are presented in Table 
3.1.  In the non-vitrified control group, 61% of the oocytes reached the MII stage, compared with 
16% in the vitrified groups (P<0.0001).  In the treatment groups, the nuclear maturation (MII) 
rate was higher (P=0.007) in oocytes vitrified on cryotop than those vitrified in straws (23 vs 9%, 
respectively).  Equilibration time did not affect the outcome (P=0.964).  Furthermore, a greater 
number of oocytes remained at the GV stage when vitrified in straws compared with those on 
cryotop (59 vs 46% respectively; P=0.045).  Equilibration time had no effect on the proportion of 
oocytes remaining at GV (P=0.497).   
 
3.4.2 Experiment 2: Effect of vitrification solutions and equilibration time on cleavage and 
embryo development   
  
Cleavage and blastocyst rates following vitrification of bovine COCs are presented in Table 3.2.  
In the control group, cleavage and blastocyst rate were higher (P<0.0001) than treatment groups.  
When the data for vitrified groups were analyzed by factorial design, fresh vs frozen solutions 
(P=0.013) and equilibration time (P=0.002) had an effect on cleavage rate. The solution x 
equilibration time interaction revealed the highest cleavage rate in COCs equilibrated for 5 min 
in frozen-thawed VS1. The blastocyst rate was low and did not differ due to equilibration times 
and the preparation method for vitrification solutions (P=0.993).  
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Table 3.1 Effect of equilibration time and cryodevice on nuclear maturation of vitrified bovine 
oocytes after 22 h in vitro maturation  
  
Oocytes 
(n) Meiotic stage 
  GVa  INTb MIIc 
    n (%) n (%) n (%) 
Non-vitrified control versus vitrified 
Non-vitrified control 54 9 (17%) 12 (22%) 33 (61%) 
Vitrified 223 118 (53%) 69 (31%) 36 (16%) 
P-value  <0.001 0.198 <0.001 
     
Equilibration time in VS1 and cryodevice     
No equilibration     
     Straw 65 44 (68%) 15 (23%) 6 (9%) 
     Cryotop 55 23 (42%) 19 (35%) 13 (24%) 
10 min equilibration     
     Straw 51 25 (49%) 21 (41%) 5 (10%) 
     Cryotop 52 26 (50%) 14 (27%) 12 (23%) 
     
P-value        
Equilibration time  0.497 0.411 0.964 
Cryodevice  0.045 0.999 0.007 
Equilibration time * cryodevice 0.032 0.043 0.901 
a Germinal vesicle (GV)    
b Intermediate (INT); germinal vesicle breakdown (GVBD) + metaphase I (MI) 
cMetaphase II (MII)    
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 3.5 Discussion  
 
In the present studies, the effect of removing equilibration in VS1 cryoprotectants on oocytes’ 
nuclear maturation, cleavage and embryo development in order to save time during the 
vitrification procedure was examined.  Our interpretation from Experiment 1 demonstrated that 
there is no beneficial effect of equilibration in VS1 on post-warm nuclear maturation of vitrified 
bovine COCs.  It is plausible that the concentrations of EG and DMSO (7.5% each) in VS1 were 
still high enough or 10 min exposure time was long enough, to cause chemical toxicity to the 
COCs.  A longer equilibration of bovine COCs in VS1 resulted in lower cleavage and blastocyst 
rates [81]. The high concentrations of cryoprotectants (EG and DMSO) are toxic to cells.  The 
chemical toxicity of EG and DMSO can be minimized by using combinations of more than one 
cryoprotectants and a stepwise exposure to cells.  The exposure of cells to lower concentrations  
58 
 
Table 3.2 Effect of vitrification solution preparation and equilibration time on cleavage and 
blastocyst rate of vitrified bovine oocytes  
 
Oocytes 
(n) 
Cleavage rate         
n (%) 
 Blastocyst rate                    
n (% of total n) 
Non-vitrified control versus vitrified 
Non-vitrified control 99 92 (93%) 31 (31%) 
Vitrified 482 201 (42%) 2 (0.4%) 
P-value  <0.001 <0.001 
      
Solution preparation and equilibration time in VS1   
Fresh    
      No equilibration 122 41 (34%) 0 (0%) 
      5 min equilibration 122 48 (39%) 0 (0%) 
Frozen    
     No equilibration 128 47 (37%) 0 (0%) 
     5 min equilibration 110 65 (59%) 2 (2%) 
        
P-value       
Solution preparation  0.013 0.993 
Equilibration time  0.002 0.993 
Solution preparation * equilibration time 0.079 <0.001 
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of cryoprotectants (in VS1) before transferring them to high concentrations (in VS2) can 
potentially reduce the toxic effect of cryoprotectants [44, 93, 94].  The equilibration of oocytes 
and embryos in VS1, which contains half of the concentration of permeating cryoprotectants of 
VS2, is generally recommended before vitrification [93, 94, 113].  It is expected to prime 
oocytes and embryos to minimize any anticipated toxic shock due to high concentration of 
cryoprotectants in VS2, i.e. 15% EG and DMSO each.  Furthermore, equilibration is thought to 
regulate the permeability of the plasma membrane, which helps in maintaining intercellular 
connections between the oocyte and cumulus cells, and may assist in avoiding quick osmotic 
changes [142].  It has been reported that equilibrating embryos results in minimal ultrastructural 
damage to the plasma membrane [143]. However, based on our results, we concluded that 10 
min equilibration of bovine COCs in VS1 may not be essential. 
 
In conventional semen and embryo cryopreservation methods, the French straw is a popular 
cryodevice (packaging system) as it is inexpensive, and cells and tissues remain sterile.  
However, vitrification of bovine oocytes in 0.25 mL straws causes a delay in heat loss from the 
solutions leading to devitrification, i.e. intracellular recrystallization during warming [82].  
Recently, considerable progress has been made in increasing cooling and warming rates by 
developing alternative packaging systems [81].  Cryodevices such as OPS [73], and cryotop [98] 
have drastically improved the cooling rate by reducing the surface to volume ratio and thus 
exposing the minuscule vitrification drop directly to LN2 [84].  In this study, cryotop and 0.25 
mL straw as a cryodevice for packaging of bovine COCs for vitrification were compared.  From 
the data, we deduced a higher nuclear maturation in COCs vitrified on cryotop than in 0.25 mL 
straw. This can be attributed to extremely fast cooling and warming rates achieved using the 
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cryotop [98].  Cryotop allows COCs to be loaded with minimal VS2 by aspirating the maximum 
VS2 surrounding COCs.  This helped in achieving an ultra-rapid cooling rate, thereby avoiding 
chilling injury.  Additionally, the extremely small volume allowed oocytes to undergo rapid 
warming rate which helped to avoid devitrification.  In 0.25 mL straws, COCs were loaded with 
a larger volume of VS2 than cryotop, which reduced the cooling rate.  Our results are consistent 
with those previously reported for vitrification of bovine [87] and porcine [99] oocytes in which 
cryotop yielded higher cleavage and blastocyst rates than OPS.  However, ovine oocytes showed 
the least parthenogenetic activation and higher blastocyst rate when vitrified in cryoloop than 
cryotop and OPS [81].      
 
In Experiment 2, the ability of vitrified bovine oocytes to achieve normal cleavage following in 
vitro fertilization using fresh or frozen-warmed solution as well as two equilibration times (0 vs 
5 min) in VS1 was examined.  From our results, we inferred frozen-warmed VS1, VS2 and 
warming solutions yielded better cleavage rates than fresh solutions, albeit for unknown reason.  
Moreover, it is unclear whether the cleavage resulted from fertilization or parthenogenesis.  The 
blastocyst rate between fresh and frozen solutions was extremely low and not different. The 
equilibration of bovine COCs in VS1 for 5 min resulted in a higher cleavage rate than no 
equilibration. It seems 5 min is an appropriate time for penetration of cryoprotectants with 
minimum toxicity. The effect of equilibration time or media preparation on blastocyst 
development was non significant.  This is in agreement with a previous report [144].  
 
In conclusion, equilibration of bovine COCs in VS1 is not essential for their in vitro nuclear 
maturation but is important for fertilization process.  Cryotop is a better cryodevice (packaging 
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system) for vitrification of bovine COCs than straws.   Furthermore, the present study revealed 
that vitrification and warming solutions can be prepared in advance and stored below 0 °C with 
no effect on cleavage or blastocyst rates following vitrification, warming and in vitro 
fertilization, which will make cryopreservation protocols more efficient and convenient. The 
results of this study can be used to optimize post-warming cleavage and blastocyst rates of 
vitrified bovine COCs.   
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CHAPTER 4: THE EFFECT OF MEIOTIC STAGE OF BOVINE OOCYTES ON THE 
SURVIVAL OF VITRIFIED CUMULUS OOCYTE COMPLEXES 
 
4.1 Abstract 
 
Vitrification is a rapid freezing method in which cells/tissues are frozen in a glass state, 
bypassing ice crystal formation.  However, vitrification of bovine oocytes is challenging due to 
their complex structure and sensitivity to chilling.  The present study aimed to evaluate in vitro 
maturation, cleavage and embryo development of bovine cumulus oocyte complexes (COCs) 
vitrified at different meiotic stages.  In Experiment 1, meiotic progression of oocytes was 
evaluated at different time intervals during in vitro maturation (IVM).  Germinal vesicle (GV), 
GV and germinal vesicle breakdown (GVBD), metaphase I (MI), and metaphase II (MII) oocytes 
were predominantly found at 0, 6, 12 and 22 h  of IVM, respectively (n > 62 per group).  In 
Experiment 2, bovine COCs at 0, 6, 12 and 22 h of IVM were exposed to vitrification solution 2 
(15% dimethyl sulfoxide + 15% ethylene glycol + 0.5 M sucrose + 20% CS in TCM-199), 
loaded onto a cryotop device and vitrified by plunging in LN2.  Following warming, COCs 
completed 22 h of IVM and nuclear stage was evaluated with lamin A/C-DAPI staining.  Upon 
completion of the 22 h of IVM, 23, 23, 35 and 89% of oocytes from 0, 6, 12 and 22 h groups, 
respectively were detected at MII (P<0.0001).  In Experiment 3, cleavage and embryo 
development of oocytes vitrified at 0, 12 and 22 h of IVM were evaluated.  The cleavage rate did 
not differ among vitrification group i.e., 14% at 0 h, 17% at 12 h and 14% at 22 h (P=0.825).  
Cleavage and blastocyst rates were higher (P<0.0001) in the non-vitrified (control) group than in 
vitrified groups, i.e., 73 vs 15% and 22 vs 0.3%, respectively. In conclusion, vitrification 
adversely affected the ability of bovine oocytes to undergo in vitro maturation to MII stage, in 
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vitro fertilization and embryo development. The nuclear stage of bovine oocytes at the time of 
vitrification had no effect on in vitro maturation, cleavage or embryo development.  
 
4.2 Introduction 
 
Many livestock breeds are losing genetic diversity due to the selection of few breeds to meet the 
market demand.  Significant progress has been made in cryopreservation of semen and embryos 
of several domestic species; however, it is very difficult to cryopreserve cumulus oocyte 
complexes (COCs). The size of oocytes, sensitivity to chilling, presence of cumulus cells, 
dynamic nature of subcellular organelles, active biochemical processes and meiosis have made it 
difficult to develop an efficient cryopreservation procedure [107]. Recently, a vitrification 
technique that employs an ultra rapid freezing velocity with higher concentrations of 
cryoprotectants was used to effectively cryopreserve mouse oocytes and has shown some success 
in other species [98, 104, 105, 107, 145]. Such a protocol for long term preservation of oocytes 
from domestic animals would be highly beneficial and would allow the development of ova 
banks permitting the storage of female (unfertilized) genetics until an appropriate sire is selected.  
 
The extent of cryoinjuries to COCs are highly variable depending on species, sensitivity to 
cooling, lipid contents and origin (in vitro and in vivo) [5, 6].  Although the results are 
controversial, meiotic stage is also thought to contribute to oocyte survivability following 
cryopreservation [50, 105-109].  Preliminary data from our laboratory demonstrated poor 
maturation rate in vitrified bovine oocytes.  Therefore, the objectives of the present study were to 
determine the maturation kinetics of bovine oocytes in our lab conditions and to evaluate the 
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effect of meiotic stage of bovine oocytes at the time of vitrification on in vitro maturation (IVM), 
cleavage and embryo development.  We hypothesized that 1) immature (GV stage) bovine 
oocytes will mature in vitro within 22 h, 2) nuclear stage of bovine oocytes at the time of 
vitrification affects their post-warm nuclear maturation in vitro, cleavage ability and 
developmental competence and 3) exposure of bovine COCs to cryoprotectant solutions affects 
their ability to become fertilized, cleave and develop into embryos.  The higher concentrations of 
cryoprotectant solutions used in vitrification procedures will have toxic effects on bovine COCs, 
resulting in poor cleavage and embryonic development.   
          
4.3 Materials and methods 
 
4.3.1 Chemicals and supplies  
  
Dulbecco’s phosphate buffered saline (DPBS), Ca-Mg free DPBS, newborn calf serum (CS), 
TCM-199 and MEM non-essential amino acids were purchased from Invitrogen Inc. (Burlington, 
ON, Canada).  Lutropin (LH) and Folltropin (FSH) were supplied by Bioniche Animal Health, 
Inc (Belleville, ON, Canada).  All other chemicals and reagents were purchased from Sigma-
Aldrich (Oakville, ON, Canada), unless otherwise stated.     
 
4.3.2 COCs collection and initial processing 
  
Bovine ovaries were collected from a slaughterhouse and transported to the laboratory at 
approximately 25 °C within 6 h.  Ovaries were washed in normal saline and extra ovarian tissues 
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were removed. Follicles <8mm in diameter were aspirated using a 18-gauge needle attached to a 
5 mL syringe containing approximately 1.0 mL of wash medium consisting of DPBS 
supplemented with 5% CS (v/v). The aspirated follicular fluid was pooled in 50 mL conical tubes 
and allowed to settle.  The COCs were searched under a stereomicroscope and washed (3x) in 
DPBS + 5% CS.  The COCs with more than three layers of cumulus cells and uniform cytoplasm 
(Grade One) were selected for further processing [136].   
 
4.3.3 Vitrification and warming procedures 
 
The COCs were exposed to three 20 µL droplets of vitrification solution 2 [VS2; TCM-199 + 
15% ethylene glycol (EG; v/v) + 15% dimethyl sulfoxide (DMSO; v/v) + 20% CS + 17.1% 
sucrose (w/v)] for less than one min at 37 ºC.  Five COCs were loaded on a cryotop (Kitazato 
Supply Co., Fujinomiya, Japan), under stereomicroscope and immediately plunged in liquid 
nitrogen (LN2).  The COCs were warmed by immersing the cryotop in a 30 mm petri dish 
containing warming solution (TCM-199 + 20% CS and 17.1% sucrose) at 37 ºC for 1 min.  The 
COCs were then washed (3x) in wash medium at 37 ºC.   
 
4.3.4 In vitro maturation, fertilization and culture  
 
The COCs were washed (3x) in maturation media (TCM-199 supplemented with 5% CS, 5 
µg/mL LH, 0.5 µg/mL FSH and 0.05 µg/mL gentamicin).  For IVM, groups of 20 COCs were 
placed in 100 µL droplets of maturation media, under mineral oil and incubated for 22 h at 38.5 
°C, 5% CO2 in air and high humidity.  For in vitro fertilization (IVF), frozen-warmed pooled 
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semen from several bulls was washed through Percoll gradient (45% and 90%) [137].  After 
washing, sperm were added to Brackett-Oliphant (BO) fertilization media [138] to a final 
concentration 3 x 106/mL.  Following 22 h of IVM, groups of 20 oocytes were washed (3x) in 
BO supplemented with 10% BSA (w/v) and added to 100 µL droplets of sperm in BO, under 
mineral oil.  After 18 h of co-incubation with sperm at 38.5 ºC, 5% CO2 in air and high humidity, 
cumulus cells and sperm attached to oocytes were mechanically removed via pipetting.  The 
presumptive zygotes were washed (3x) through in vitro culture (IVC) medium CR1aa with 5% 
CS, 2% BME essential amino acids (v/v), 1% MEM nonessential amino acids (v/v), 1% L-
Glutamic acid (v/v), 0.3% BSA and 0.05 µg/mL gentamicin, transferred in 100µL IVC droplets 
under mineral oil and incubated at 38.5 ºC under 5% CO2, 90% N2, 5% O2 and high humidity.  
After 48 h in culture, cleavage rate was recorded and embryo culture was continued in the same 
drops.  Blastocyst rate was recorded on Days 7, 8 and 9 (Day 0= day of IVF).    
 
4.3.5 Immunohistochemistry for evaluation of oocyte’s nuclear maturation   
    
To assess nuclear maturation, oocytes were immunostained using lamin-AC/DAPI procedure 
(Anzar et al, unpublished).  The COCs were completely denuded by pipetting with 0.3% 
hyaluronidase in Ca-Mg free Dulbecco’s phosphate buffered saline (DPBS) and fixed with 4% 
paraformaldehyde (w/v) in DPBS.  All steps were performed at room temperature and oocytes 
were washed in DPBS (3x) between steps.  Oocytes were permeabilized with 0.5% Triton X-100 
(v/v) in DPBS for 30 min followed by 0.05% Tween-20 (v/v) (BIO-RAD, Hercules, CA, USA) 
in DBPS for 30 min.  Oocytes were then placed in a blocking buffer (2% BSA in DPBS) for 60 
min.  Oocytes were added to mouse anti-lamin A/C (1:300) (Santa Cruz Biotechnology, Santa 
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Cruz, CA, USA) in DPBS + 2% BSA followed by 1:200 secondary antibody Alexa 488 labeled 
anti-mouse IgG (Santa Cruz Biotechnology) in DPBS + 2% BSA, each for 60 min.  Oocytes 
were transferred through three 5 µl-drops of Vectashield Mounting Medium containing DAPI 
(Vector Laboratories Inc., Burlingame, CA, USA), mounted on a microscope glass slide under 
coverslip (using paraffin-vaseline support at each corner of the coverslip to prevent oocyte 
rupture) and examined using Zeiss epi-fluorescence microscope for nuclear stage.  Nuclear status 
was classified into one of four stages: germinal vesicle (GV), germinal vesicle breakdown 
(GVBD), metaphase I (MI), and metaphase II (MII), as shown in Figure 4.1.  For data analysis, 
the oocytes at GV and MII stages were considered immature and fully mature, respectively. 
 
4.3.6 Experimental design 
 
4.3.6.1 Experiment 1: Kinetics of nuclear maturation 
 
The COCs were incubated in maturation medium in groups of 20 for 0, 6, 12 and 22 h in four 
replicates. Oocyte nuclear maturation was examined at the end of IVM using the lamin A/C-
DAPI staining procedure as described above.    
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Figure 4.1 Classification of bovine oocytes using lamin A/C DAPI staining method:  
Germinal Vesicle (GV; A), Germinal Vesicle Breakdown (GVBD; B), Metaphase I (MI; C) and 
Metaphase II (MII; D).   
 
   
 
 
 
 
 
 
 
A 
C 
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D 
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4.3.6.2 Experiment 2: Maturation of oocytes vitrified at different nuclear stages 
 
The COCs were vitrified at 0, 6, 12 and 22 h of IVM, warmed, washed (3x) then placed in 100 
µL droplets of maturation medium to complete 22 h of IVM.  Oocytes vitrified at 22 h were 
considered as positive controls because they were expected to be mature at the time of 
vitrification.  The COCs that were neither vitrified nor in vitro matured (i.e. non-vitrified COCs 
at 0 h) were considered as control.  The nuclear status of oocytes was evaluated using lamin A/C-
DAPI staining as described above.  This experiment was replicated five times on different dates. 
 
4.3.6.3 Experiment 3: Developmental competence of oocytes vitrified at different nuclear 
stages 
 
The COCs matured for 0, 12 or 22 h were vitrified, warmed, washed (3x) in maturation media, 
and then returned to 100 µL droplets of maturation medium to complete 22 h of IVM.  Both the 
control (non-vitrified) and the vitrified oocytes underwent IVF and subsequent IVC.  Cleavage 
was evaluated on Day 2 (Day 0= day of IVF) and blastocyst rates were determined on Days 7, 8 
and 9.  This experiment was replicated three times on different dates. 
 
4.3.7 Statistical analysis 
 
The level of significance was set at P<0.05.  Analyses were conducted on each data set with proc 
glimmix in SAS® version 9.2 [141] using binary distribution (for yes/no response variable) and 
considering replicate as a random factor.  In Experiments 1 and 2, the effect of time on 
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maturation stage (GV, GVBD, MI and MII) was examined.  In Experiment 2, 0 h non-vitrified 
control and 22 h vitrified groups were for comparative purposes and were not included in the 
second analyses, which compared only 0, 6 and 12 h groups.  In Experiment 3, initial analysis 
compared the cleavage and blastocyst rates between non-vitrified (control) and vitrified groups 
(combined data from 0, 12 and 22 hr vitrified groups). A second analysis compared the effect of 
vitrification at 0, 12 and 22 h after initiation of IVM on maturation, cleavage and blastocyst rates 
within vitrified groups (i.e., excluding non-vitrified control).  
 
4.4 Results 
 
4.4.1 Experiment 1: Kinetics of nuclear maturation 
 
Data on oocytes at GV, GVBD, MI and MII during 22 h of maturation are presented in Figure 
4.1.  The frequency of GV was greater (P<0.05) at 0 h (89%) than the other time periods 
examined.  At 6 h, 47% of oocytes were GV, whereas 44% were GVBD.  The frequency of MI 
(90%) and MII (84%) oocytes was higher (P<0.05) at 12 and 22 h respectively, during in vitro 
maturation, than other time periods.   
 
4.4.2 Experiment 2: Maturation of oocytes vitrified at different nuclear stages 
 
Data on maturation rates following vitrification at different times in IVM are shown in Table 4.1.  
In the non-vitrified control group, 90% of oocytes were immature GV at 0 h compared to less 
than 15% GV oocytes at 0 h in all other groups (P<0.001).  Higher number of oocytes were 
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detected at MII stage in the group vitrified at 22 h (i.e., positive control; 89%, 109/123) than 
those vitrified at 0, 6 and 12 h (P<0.05). When vitrification was performed at or before MI (data 
combined for 0, 6 and 12 h groups), 25% (97/359) of COCs reached MII.  Maturation (MII) of 
oocytes vitrified at 0, 6 and 12 h of IVM did not differ (P>0.05). However, a chi-square 
comparison detected a difference (P=0.027) in MII rate between 12 h group (35%; 42/121) 
compared to 0 h and 6 h groups combined (23%; 55/238).  Compared to 6 and 12 h, a 
considerable proportion of oocytes vitrified at 0 h (14%) remained at GV stage following 22 h in 
vitro maturation.   
 
4.4.3 Experiment 3: Developmental competence of oocytes vitrified at different nuclear stages 
 
Data on cleavage and embryo development of non vitrified controls and vitrified oocytes are 
shown in Table 4.2.  Cleavage and blastocyst rates were higher in non-vitrified (control) COCs 
(73 and 22%, respectively) than vitrified COCs (0, 12 and 22 h groups combined; 15%; and 
0.3%, respectively).  Within vitrification groups, cleavage rates did not differ.  No blastocyst 
developed in the 0 and 22 h groups; however, the blastocyst rate as a percentage of oocytes 
cleaved was 6% in the 12 h group.  Due to low numbers, no statistical comparisons were done on 
blastocyst rates between treatment groups. 
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Figure 4.2 Classification of oocyte meiotic stage (GV: germinal vesicle, GVBD: germinal 
vesicle breakdown, MI: metaphase I and MII: metaphase II) by lamin A/C-DAPI staining 
procedure at 0, 6, 12 and 22 h of in vitro maturation  
*Different superscripts (a, b, c) denote difference within nuclear stage  
**Different superscripts (A, B, C) indicate difference within in vitro maturation time (0, 6, 12 
and 22 h) 
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Table 4.1 Ability of bovine oocytes vitrified at different meiotic stages to complete maturation  
  
Oocytes 
(n) 
Meiotic stage 
 
  GVa  GVBDb MIc MIId 
    n (%) n (%) n (%) n (%) 
0 h (non-vitrified 
control) 113 102 (90%) 6 (5%) 3 (3%) 2 (2%) 
22 h (positive 
control) 123 1 (1%) 0 (0%) 13 (11%) 109 (89%) 
      
IVM time at vitrification*         
0 h 127 18 (14%) 54 (43%) 26 (20%) 29 (23%) 
6 h 111 3 (3%) 30 (27%) 52 (47%) 26 (23%) 
12 h 121 0 (0%) 2 (2%) 77 (64%) 42 (35%) 
      
P-value   0.013 <0.001 <0.001 0.068 
a Germinal vesicle (GV)      
bGerminal vesicle breakdown (GVBD)    
cMetaphase I (MI)     
dMetaphase II (MII)     
*The 22 h of IVM was completed following vitrification and warming 
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Table 4.2 Cleavage and developmental rates of bovine oocytes vitrified at different meiotic 
stages 
  Oocytes 
(n) 
Cleavage rate Blastocyst rate Blastocyst rate 
 n (%) n (% of total) (% of cleaved) 
Non-vitrified control vs. vitrified      
Non-vitrified control 103 75 (73%) 23 (22%) (31%) 
Vitrified 286 43 (15%) 1 (0.3%) (2%) 
P-value  <0.001 <0.001 <0.001 
     
IVM time at vitrification        
0 h 84 12 (14%) 0 (0%) (0%) 
12 h 95 16 (17%) 1 (1%) (6%) 
22 h 107 15 (14%) 0 (0%) (0%) 
P-value   0.825 - - 
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4.5 Discussion 
 
In the present study, in vitro maturation, cleavage and embryo development following 
vitrification of bovine oocytes at different nuclear stages were examined.  Only 25% of COCs 
reached the MII stage when vitrification was performed at or before MI compared to 85% in 
control (non-vitrified group in Experiment 1).  However, a greater proportion of oocytes 
progressed from MI to MII if vitrification occurred at MI rather than at GV or GVBD.  Most 
oocytes vitrified at the GV stage (0 h) proceeded to GVBD and MI upon resumption of IVM.  
Comparable cleavage rates in COCs vitrified after 0, 12 or 22 h of IVM indicate that survival is 
similar at different meiotic stages.  The estimated cleavage rate of surviving COCs after 
vitrification (60%; 15% oocytes cleaved/25% oocytes developing to MII) was similar to non-
vitrified control (88%; 74% oocytes cleaved/85% developing to MII).  When calculating the 
blastocyst rate as a percentage of cleaved oocytes, 2% of vitrified oocytes developed to the 
blastocyst stage.  This indicates that fertilization failure may not be the major cause of failure of 
embryonic development.  Rather, vitrification may affect genomic activation of cleaved 
embryos, i.e., embryonic failure occurred at the early stages of growth as indicated by arrested 
development at 2 to 8 cell stage. 
 
The results of the first study confirmed that most oocytes were at GV stage at the time of 
aspiration from ovarian follicles and that they followed the expected normal kinetics of oocyte 
maturation during IVM.  Our data on the occurrence of different nuclear stages, i.e., GV, GVBD, 
MI and MII, at different times during IVM are comparable to other published studies, validating 
our maturation protocol [106, 109].   
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There is a controversy in literature regarding the suitable nuclear stage for oocyte vitrification.  
In some reports, stage of nuclear maturation of oocytes had no effect on survival following 
cryopreservation  [80, 106]; whereas in others GV [105, 135], GVBD [146] and MII [50, 147] 
were the most suitable stages for vitrification of oocytes [109].  In the present study, nuclear 
stage at vitrification had no effect on oocyte maturation, cleavage or blastocyst development.    
 
In Experiment 2, the proportion of vitrified oocytes reaching MII did not differ between 0, 6 and 
12 h treatment (vitrified) groups.  The lower maturation rates in oocytes vitrified at 0, 6 and 12 h 
(Table 4.1) than in non-vitrified controls (Figure 4.1), indicate that severe cellular damage 
occurred during vitrification.  Although the oocytes were vitrified at different nuclear stages, a 
proportion of vitrified oocytes reaching MII stage in all groups indicate survival and the ability 
to mature in vitro.; i.e. in comparing the proportion of oocytes at MII in Experiments 1 and 2, 
respectively: 1 vs 23% were MII at 0 h, 4 vs 23% were MII at 6 h and 5 vs 35% were MII at 12 
h.  Furthermore, the percentage of oocytes that remained at the GV stage following vitrification 
and completion of the 22 h of IVM were lower in Experiment 2 compared to Experiment 1 
respectively: 0 h (89 vs 14%) and 6 h (46 vs 3%).  This indicated survival following vitrification 
from the ability of the vitrified oocytes to resume IVM following warming.  Oocytes vitrified 
after 22 h IVM had a higher maturation rate (89% MII, Table 4.1), but the data in Experiment 1 
indicate that 84% of oocytes had already reached the MII stage at the time of vitrification (Figure 
4.1).  Therefore, the survival rate of oocytes following 22 h of IVM cannot really be evaluated 
until cleavage following IVF was assessed.  
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During the progression from the GV to MII stage, oocytes undergo several changes.  Alterations 
in the synthesis and storage of proteins and RNA, reorganization and migration of organelles and 
cortical granules, cytoplasmic and perivitelline space changes, as well as morphological 
transformations in cumulus cells are all associated with the transition from diplotene stage of the 
first meiotic prophase to metaphase II and the extrusion of the first polar body [109].  
Consequently, they did not undergo maturation, as witnessed in Experiment 2, or become 
fertilized and subsequently cleave and develop to blastocysts, as witnessed in Experiment 3.  
Therefore it can be postulated that many of the vitrified oocytes did not undergo the changes 
necessary for progression from GV to MII stage, possibly due to damage of organelles during 
vitrification.   
 
Nuclear stage at the time of vitrification appears to have no effect on fertilization or embryo 
development (Experiment 3).  However, cleavage and blastocyst rates were significantly lower in 
the vitrified groups than in the non-vitrified control group, suggesting that developmental 
competence for blastocyst formation was impaired in vitrified bovine oocytes.   
 
Spindle disorganization followed by microtubule depolymerization has been reported to be a 
common manifestation in vitrified MII oocytes [50, 109, 148].  Such damage can result in 
chromosome scattering or increased polyploidy due to incomplete second meiosis at fertilization.  
Therefore, the cryopreservation of immature GV oocytes has been preferred because the meiotic 
spindle is not organized and the genetic material is confined within the nucleus at this stage of 
development.  However, immature, GV oocytes are thought to be more sensitive to anisomotic 
stress and have lower cell membrane stability than MII stage oocytes [107].  Success in the 
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cryopreservation of immature oocytes largely depends on the ability to preserve the structural 
and functional integrity of the entire oocyte and cumulus cells surrounding the oocyte.  Freezing 
damage associated with structural injury to the membrane and destruction of gap junctions, result 
in disruption of intercellular communication between the oocyte and cumulus cells [50, 105, 107, 
149].   
 
Cryopreservation of an intermediate stage oocyte, such as GVBD, has been thought to avoid 
some of the cryoinjuries associated with cryopreservation of GV or MII oocytes [107].  A study 
done in 1998 examined the effect of vitrifying oocytes following 0, 6, 12 and 24 h of IVM on the 
survival of bovine oocytes.  The authors found that vitrification of oocytes following 12 h of 
IVM seemed to be result in higher survival rates than other stages of maturation, since the 
fertilization rate was the highest (36%) among the vitrification groups [105].  However, Men et 
al. (2002) concluded that MII stage oocytes had more resistance to cryopreservation than GVBD 
stage oocytes, as indicated by the higher proportion of cleaved embryos from vitrified MII 
oocytes that developed into blastocysts than vitrified GVBD oocytes (1 vs 8%, respectively) 
[50].  Regardless of the nuclear stage cryopreserved, successful fertilization also depends on 
cytoplasmic maturation and consequently, any damage to cytoplasmic membrane may 
compromise the viability of oocytes [147].  
 
Our results revealed no differences in embryo developments among oocytes vitrified at different 
nuclear stages, which support the findings of others [80, 106].  The vitrified oocytes had low 
rates of embryo development when compared to non-vitrified controls, indicating probable 
damage to the cells during vitrification, regardless of the stage of nuclear maturation.  Possible 
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adverse consequences of cryopreservation include osmotic injury, toxic effects of 
cryoprotectants, concentrated intracellular electrolytes, ice crystal formation and chilling which 
have been reported to lead to zona fracture and alterations in intracellular organelles and 
cytoskeleton [150].  Vitrification has also been reported to cause the premature release of cortical 
granules, resulting in the modification of the zona pellucida and corresponding alterations in 
blockage of sperm entry [149, 151].  Aneuploidy and polyploidy have been reported to be 
leading causes of compromised developmental competence following cryopreservation of bovine 
oocytes [147, 152].  Moreover, chilling can cause apoptosis, chromosomal aberrations, 
modifications in mitochondria and nucleoli, as well as irreversible phase changes of lipid 
bilayers and membrane lysis [148, 153].   
 
Following warming in the present studies, vitrified COC underwent some degree of cumulus 
expansion; however, this was not recorded and compared to non-vitrified controls.  Another 
observation from the present study was that cumulus cells from vitrified oocytes were easier to 
remove than from the non-vitrified controls, possibly due to damage to the cumulus-oocyte gap 
junctions which are required for nuclear and cytoplasmic meiotic competence [106].  Damage to 
gap junctions could result in reduced oocyte maturation and subsequent embryo development, as 
was observed in Experiment 3 [109].   
       
In conclusion, nuclear maturation, fertilization and embryo development of vitrified bovine 
oocytes was lower than in non-vitrified control oocytes, likely due to cryodamage.  Results from 
this study indicate that a greater proportion of oocytes transition from MI to MII if vitrification 
occurs at MI rather than at GV and GVBD stages.  Nuclear status of vitrified oocytes had no 
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effect on fertilization or subsequent embryo development.  Future studies are required to reduce 
cryo-injuries to bovine oocytes and COC, and to study the mechanisms involved in reduced 
embryonic development of vitrified bovine oocytes. 
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CHAPTER 5: EFFECT OF LENGTH OF EXPOSURE TO CRYOPROTECTANT AND 
WARMING SOLUTIONS, AND VITRIFICATION OF BOVINE CUMULUS OOCYTE 
COMPLEXES ON CLEAVAGE AND SUBSEQUENT EMBRYO DEVELOPMENT 
 
 
5.1 Abstract 
 
The present studies aimed to evaluate the effect of time interval of exposure of bovine cumulus 
oocyte complexes (COCs) to cryoprotectant and warming solutions, and vitrification on cleavage 
and subsequent embryo development following in vitro fertilization (IVF).  In Experiments 1 and 
2, COCs were exposed to vitrification solution 1 [VS1; TCM-199 + 7.5% ethylene glycol (EG) + 
7.5% dimethyl sulfoxide (DMSO) + 20% calf serum (CS)] for 5 min (Group 1), VS1 followed 
by vitrification solution 2 (VS2; TCM-199 + 15% EG + 15% DMSO + 0.5 M sucrose + 20% 
CS) for 1 min (Group 2) and VS1 and VS2 followed by vitrification in liquid nitrogen using 
cryotop method and 1 min in warming solution (TCM-199 + 0.5 M sucrose + 20% CS), (Group 
3).  In Experiment 2, COCs in VS1, VS1+VS2 and vitrified groups were exposed to the warming 
solution for either 1 or 5 min.  In both experiments, all COCs underwent in vitro maturation 
(IVM), IVF and in vitro culture (IVC).  Untreated (non-vitrified) COCs underwent IVM, IVF 
and IVC as controls.  Cleavage and blastocyst rates (as a percentage of cleaved oocytes) in the 
vitrified group (41 and 4% in Experiment 1, and 25 and 7% in Experiment 2, respectively) were 
lower (P<0.001) than in the other groups (non-vitrified controls, 92 and 37% in Experiment 1 
and 75 and 36% in Experiment 2; VS1 group, 79 and 32% in Experiment 1 and 68 and 29% in 
Experiment 2; VS1+VS2 group, 80 and 26% in Experiment 1 and 63 and 36% in Experiment 2). 
Cleavage and blastocyst rates did not differ between control, VS1 and VS1+VS2 groups.  In 
Experiment 2, warming time did not affect cleavage rates.  In conclusion, the cryoprotectants 
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(EG and DMSO) present in VS1 and VS2 had no adverse effects on cleavage and blastocyst rates 
of bovine COCs.  However, vitrification of bovine COCs drastically reduced cleavage and 
blastocyst rates.   
 
5.2 Introduction 
  
Developing a reliable method for cryopreservation of oocytes would have numerous applications 
for assisted conception in humans, animal breeding programs, and conservation of female animal 
genetic resources.  Oocyte cryopreservation has been performed in several mammalian species; 
however, the success rate is extremely low. Conventional slow freezing is commonly used for 
cryopreservation of embryos; however, cellular damage often results from intracellular ice 
formation [48].  Therefore, vitrification is being used increasingly for cryopreserving tissue, 
embryos and oocytes to avoid chilling injury [135, 154, 155].  It does not require expensive 
coolers, special skill and is a fairly quick procedure.      
 
Vitrification uses ultra-rapid cooling and warming rates to pass the oocyte through critical 
temperature zones quickly [48].  It results in solid-glass formation in the oocyte and surrounding 
solution, due to the increased viscosity from the high concentration of cryoprotectants and rapid 
cooling [156].  Although successful vitrification has been reported in mouse oocytes [145], 
vitrification of bovine oocytes is challenging due to their complex structure and sensitivity to 
chilling [120].  Studies in our lab examined the effect of vitrification of bovine oocytes on 
nuclear maturation, cleavage and blastocyst development (Chapter 4).  We concluded that 
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compared to non-vitrified oocytes, those which were vitrified had reduced embryo 
developmental competence, as indicated by low blastocyst rates (<5%).     
 
The main biophysical factor causing cellular disruption during cryopreservation is intracellular 
ice crystal formation; however, this may be reduced or diminished by increasing the viscosity of 
the solution by using proper cryoprotectants at higher concentrations [48, 109].  The most 
commonly used permeating cryoprotectants for oocyte cryopreservation are ethylene glycol 
(EG), propylene glycol, glycerol and dimethyl sulfoxide (DMSO) [157].  Despite the critical 
importance of cryoprotectants for avoiding ice crystal formation in oocytes, the higher 
concentrations of cryoprotectants required for vitrification may be toxic and can result in osmotic 
injury to the cell, leading to reduced developmental competence [156, 158].  To investigate the 
low success rate after vitrification, it is important to examine the individual components of the 
system.  Therefore, we wanted to determine the role of cryoprotectant solutions in the observed 
reduced rates of cleavage of vitrified bovine oocytes and subsequent embryo development. 
 
During warming, it is essential to remove cryoprotectants and rehydrate the oocyte [159].  
Oocyte swelling during warming (dilution) is an important determining factor for survival as 
volume fluctuations affect the plasma membrane integrity and cytoskeletal organization [160].  
The proper warming time for vitrified oocytes is still uncertain.  If the time in the warming 
solution is insufficient, cryoprotectants may not be completely removed and when directly 
exposed to an isotonic solution, water diffuses into the cell faster than the cryoprotectants flow 
out and osmotic swelling can occur beyond the volume limits of the oocyte [95].  Although 
oocytes can withstand a certain amount of swelling, if the volume fluctuation goes beyond the 
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critical volume, irreversible membrane damage can occur.  Therefore, the present studies aimed 
to investigate the effect of the time intervals of exposure of bovine cumulus oocyte complexes 
(COCs) to cryoprotectant and warming solutions and vitrification on cleavage and subsequent 
embryo development following in vitro fertilization.   We hypothesized that 1) the higher 
concentrations of cryoprotectant solutions used in vitrification procedures would have toxic 
effects on bovine COCs, resulting in poor cleavage and embryonic development and 2) warming 
vitrified COCs for a longer interval would improve the removal of intracellular cryoprotectants 
resulting in higher cleavage and blastocyst production rates.   
          
5.3 Materials and methods 
 
5.3.1 Chemicals and supplies  
  
Dulbecco’s phosphate buffered saline (DPBS), Ca-Mg free DPBS, newborn calf serum (CS), 
TCM-199 and MEM non-essential amino acids were purchased from Invitrogen Inc. (Burlington, 
ON, Canada).  Lutropin (LH) and Folltropin (FSH) were supplied by Bioniche Animal Health, 
Inc (Belleville, ON, Canada).  All other chemicals and reagents were purchased from Sigma-
Aldrich (Oakville, ON, Canada), unless otherwise stated.     
 
5.3.2 COCs collection and initial processing 
  
Bovine ovaries were collected from a slaughterhouse and transported to the laboratory at 
approximately 25 °C within 8 h.  Ovaries were washed in normal saline and extra ovarian tissues 
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were removed. Follicles <8mm in diameter were aspirated using a 18-gauge needle attached to a 
5 mL syringe containing approximately 1.0 mL of wash medium consisting of DPBS 
supplemented with 5% CS (v/v). The aspirated follicular fluid was pooled in 50 mL conical tubes 
and allowed to settle.  The COCs were searched under a stereomicroscope, washed (3x) in DPBS 
+ 5% CS and COCs with more than three layers of cumulus cells and uniform cytoplasm (Grade 
One) were selected for further processing [136].   
 
5.3.3 Vitrification and warming procedures 
 
The COCs were vitrified by equilibrating in vitrification solution 1 (VS1; TCM-199 + 7.5% 
ethylene glycol (EG; v/v) + 7.5% dimethyl sulfoxide (DMSO; v/v) + 20% CS) for 10 min at 37 
°C.  After equilibration, COCs were transferred through three 20 µL-drops of vitrification 
solution 2 [VS2; TCM-199 + 15% EG+ 15% DMSO + 20% CS + 17.1% sucrose (w/v)] at 37 °C 
for a total exposure time of < 1 min.  Five COCs were loaded on a cryotop (Kitazato Supply Co., 
Fujinomiya, Japan), under stereomicroscope and immediately plunged in liquid nitrogen (LN2).  
The COCs were warmed by immersing the cryotop in a 30 mm petri dish containing warming 
solution (TCM-199 + 20% CS and 17.1% sucrose) at 37 ºC for 1 min.  The COCs were then 
washed (3x) in wash medium at 37 ºC.   
 
5.3.4 In vitro maturation fertilization and culture  
 
The COCs were washed (3x) in maturation media (TCM-199 supplemented with 5% CS, 5 
µg/mL LH, 0.5 µg/mL FSH and 0.05 µg/mL gentamicin).  For IVM, groups of 20 COCs were 
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placed in 100 µL droplets of maturation media, under mineral oil and incubated for 22 h at 38.5 
°C, 5% CO2 in air and high humidity.  For in vitro fertilization (IVF), frozen-warmed pooled 
semen from several bulls was washed through Percoll gradient (45% and 90%) [137].  After 
washing, sperm were added to Brackett-Oliphant (BO) fertilization media [138] to a final 
concentration 3 x 106/mL.  Following 22 h of IVM, groups of 20 oocytes were washed (3x) in 
BO supplemented with 10% BSA (w/v) and added to 100 µL droplets of sperm in BO, under 
mineral oil.  After 18 h of co-incubation with sperm at 38.5 ºC, 5% CO2 in air and high humidity, 
cumulus cells and sperm attached to oocytes were mechanically removed via pipetting.  The 
presumptive zygotes were washed (3x) through in vitro culture (IVC) medium CR1aa with 5% 
CS, 2% BME essential amino acids (v/v), 1% MEM nonessential amino acids (v/v), 1% L-
Glutamic acid (v/v), 0.3% BSA and 0.05 µg/mL gentamicin, transferred in 100µL IVC droplets 
under mineral oil and incubated at 38.5 ºC under 5% CO2, 90% N2, 5% O2 and high humidity.  
After 48 h in culture, cleavage rate was recorded and embryo culture was continued in the same 
drops.  Blastocyst rate was recorded on Days 7, 8 and 9 (Day 0= day of IVF).    
 
5.3.5 Experimental design 
 
5.3.5.1 Experiment 1: Effect of cryoprotectant exposure and vitrification on cleavage and 
embryo development  
 
The COCs were divided into the following four groups:  1) control group: COCs were held in 
wash medium  2) VS1 group: COCs were exposed to VS1 for 5 min then kept in wash medium;  
3) VS1+VS2 group: COCs were exposed to VS1 for 5 min followed by VS2 for <1 min, and 
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were then kept in wash medium; 4) vitrified group: COCs were exposed to VS1 for 5 min and 
VS2 for <1 min, vitrified in LN2 using cryotop method, warmed at 37ºC in warming solution for 
1 min and transferred to wash medium.  After treatments, all COCs underwent in vitro 
maturation, fertilization and embryo culture, as described above.  This experiment was replicated 
five times on different dates.    
 
5.3.5.2 Experiment 2: Effect of length of exposure to cryoprotectant and warming solutions, 
and vitrification of bovine COCs on cleavage and embryo development 
 
As in Experiment 1, COCs were randomly divided into VS1, VS1+VS2 and vitrified groups; 
however, the COCs in VS1, VS1+VS2 and vitrified groups were sub-divided and exposed to 
warming solution for either 1 or 5 min, followed by wash medium.  The COCs which were not 
exposed to cryoprotectants served as controls.  All COCs then underwent in vitro maturation, 
fertilization and embryo culture.  This experiment was replicated five times on different dates.   
 
5.3.6 Statistical analyses 
 
Data were analyzed using Proc Glimmix in SAS® Enterprise Guide 4.2 [141].  Analyses were 
performed using randomized complete block design modeling binary distribution (for yes/no 
response variable) for cleavage and blastocyst rates. Main effects and interactions were 
considered statistically different at a P-value <0.05 . The effect of control, VS1, VS1+VS2 and 
vitrification were examined for cleavage and blastocyst rates in Experiment 1.  In Experiment 2, 
analyses were performed using 2x2 factorial randomized complete block design.  Replicate 
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number (1 to 5), treatment (1=control, 2=VS1, 3= VS1+VS2, 4=vitrified), warming time (1=1 
min warming time, 2=5 min warming time) and binomial response (1=cleavage, 2=no cleavage) 
were recorded for each oocyte.  Syntax of SAS program was: Proc glimmix method=quad; class 
replicate treatment warming time; model cleavage (event=”1”) =treatment|warming time 
/dist=bin link=logit; random intercept/ subject=replicate; run; If the P-value for 
treatment*warming time interaction term from Type III sum of squares was <0.05, then lsmeans 
treatment warming time/ diff lines ilink or adjust= tukey; was added to the syntax for separation 
of group means.  
 
5.4 Results 
 
5.4.1 Experiment 1: Effect of cryoprotectant exposure and vitrification on cleavage and 
embryo development 
  
Data on effect of exposure to cryoprotectant solutions and vitrification on oocyte cleavage and 
embryo development are presented in Table 5.1.  The cleavage rate of oocytes from control 
group (92%), (not exposed to cryoprotectants or cooling), did not differ from the VS1 (79%) or 
VS1+VS2 (80%) groups (P>0.05).  However, the cleavage rate from the vitrified group (41%) 
was lower (P<0.001) than control, VS1 and VS1+VS2 groups.  The blastocyst rate in the control 
group (34%) did not differ (P>0.05) from the VS1 (25%) or VS1+VS2 (21%) groups, but all 
differed (P<0.001) from the vitrified group (2%).      
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Table 5.1 Effect of cryoprotectant exposure and vitrification on cleavage of bovine oocytes and 
subsequent embryo development.   
 Oocytes (n) Cleavage rate Blastocyst rate Blastocyst rate 
    n (%) n (% of total n) (% of cleaved) 
Non-exposed 
(control) 90 83 (92%) 31 (34%) 37% 
VS1 107 85 (79%) 27 (25%) 32% 
VS1+VS2 96 77 (80%) 20 (21%) 26% 
Vitrified   127 52 (41%) 2 (2%) 4% 
P-value        
aCryoprotectant exposure 0.847 0.456  
bVitrification   <0.001 <0.001   
aAnalysis excluded vitrified group    
bAnalysis of all groups    
VS1: Vitrification solution 1 
VS2: Vitrification solution 2 
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5.4.2 Experiment 2: Effect of length of exposure to cryoprotectant and warming solutions, and 
vitrification of bovine COCs on cleavage and embryo development 
 
Data on effect of time in cryoprotectant and warming solutions and vitrification on cleavage and 
blastocyst rates are presented in Table 5.2.  There was no effect (P>0.05) of time in the warming 
solution on cleavage and embryo development.  Both cleavage and blastocyst rates in the 
vitrified group (25 and 0.6%, respectively) were lower (P<0.001) than in non-vitrified control 
(75 and 27%, respectively), VS1 (68 and 20%, respectively) or VS1+VS2 (63 and 23%, 
respectively) groups, which did not differ from one another (P>0.05).   
 
 
5.5 Discussion 
 
In the present study, the effects of length of exposure to vitrification and warming solutions and 
vitrification on in vitro fertilization and subsequent embryo development of bovine COCs was 
examined.  Results indicated that exposure of immature bovine COCs to cryoprotectants 
commonly used in vitrification procedures had no adverse effect on cleavage or embryo 
development.  However, embryonic developmental was compromised by of the vitrification 
procedure, suggesting that cooling is causing cellular damage.  Furthermore, this study indicated 
that a period of 5 min in warming solution did not result in additional increase in oocyte 
viability, when compared to 1 min.    
 
Vitrification requires very high concentrations of cryoprotectants to reduce the probability of  
 
intracellular ice crystal formation.  However, there is a biological limit to the ability of oocytes to 
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Table 5.2 Effect of time in cryoprotectant and warming solutions on cleavage of bovine oocytes 
and subsequent embryo development   
 Oocytes (n) Cleavage rate  Blastocyst rate  Blastocyst rate 
    n (%) n (% of total n) % of cleaved 
Non-exposed (control) 81 61 (75%) 22 (27%) 36% 
VS1     
     1 min warming interval 82 60 (73%) 16 (20%) 27% 
     5 min warming interval 77 48 (62%) 15 (20%) 31% 
VS1+VS2     
     1 min warming interval 87 52 (60%) 16 (18%) 31% 
     5 min warming interval 82 54 (66%) 22 (27%) 41% 
Vitrified     
     1 min warming interval 74 22 (30%) 1 (1%) 5% 
     5 min warming interval 98 21 (21%) 2 (2%) 10% 
P-value     
aCryoprotectant exposure 0.202 0.205  
bWarming time  0.241 0.689  
bCryoprotectant exposure * warming time 0.381 0.687  
cVitrification   <0.001 <0.001  
aAnalysis excludes vitrified groups     
bAnalysis excludes control   
cAnalysis of all groups   
VS1: Vitrification solution 1 
VS2: Vitrification solution 2 
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 tolerate the osmotic stress associated with high concentrations of cryoprotectants [84]. Our 
findings suggest that it was the ultra-rapid cooling of bovine oocytes during vitrification that 
adversely affected cleavage and embryo development, rather than the high concentrations of 
cryoprotectants (EG and DMSO).  In both Experiments 1 and 2, exposure to VS1 and VS1+VS2 
did not adversely affect cleavage and blastocyst rates.  However, vitrification drastically reduced 
cleavage and embryo development rates, a consequence of the sensitivity of bovine COCs to 
cooling, as has been suggested by others [158].    
 
Recently, there has been much debate about the use of DMSO in vitrification solutions on the 
Embryo Mail Website [161]. Oocyte vitrification using DMSO alone [162] or in combination 
with other cryoprotectants [112] has been reported to be successful.  However, contradictory 
findings report the use of DMSO (alone or in combination with EG) can reduce the 
developmental competence of oocytes [156, 158].  Although DMSO-free vitrification systems 
have shown promising results with embryos [163, 164], results have not been as favorable for 
oocytes [165].  The ideal cryoprotectant solution has high permeability and low toxicity, but 
there has been no such optimal cryoprotectant combination described to date.   
 
Several reports have shown that cryoprotective agents interfere with tubulin and filamentous 
actin structures of the cytoskeleton of oocytes [159, 166, 167].  Moreover, cryoprotectants have 
been thought to cause premature cortical granule release resulting in zona hardening and reduced 
subsequent fertilization rates [7, 159, 168].  In the present studies, COCs exposed to 
cryoprotectants (without vitrification) had satisfactory cleavage and blastocyst rates suggesting 
that sperm penetration was apparently not an issue.  In this regard, CS has been reported to be 
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protective against zona hardening and defective blocking of polyspermy in the mouse [169].  In 
the present studies, the CS used in the vitrification and warming solutions may have had a 
protective effect against osmotic and toxic effects of cryoprotectant exposure [7].   
 
Cleavage and blastocyst development following cryoprotectant exposure did not differ from non-
treated controls in the present experiments supporting a previous report in which the 
cryoprotectant and concentration had no effect on microtubule polymerization in matured ovine 
oocytes [81].  Likewise, Hochi et al (2001) found no adverse effects of vitrification solutions 
containing 1.5 and 3.0 M EG for 5 min each followed by 1 min in 7.2 M EG and 1.0 M sucrose 
on morphological survival, sperm penetration and fertilization of bovine oocytes [170]. 
Moreover, DMSO did not result in damage to microorganelles related to normal oocyte 
morphology and sperm penetration [171].  
 
Bovine oocytes have been cryopreserved at different nuclear stages (germinal vesicle, germinal 
vesicle breakdown, metaphase I and metaphase II).  However, mature oocytes have meiotic 
spindles that are extremely sensitive to cooling and exposure to cryoprotectants, which often 
results in tubulin depolymerization [89, 156, 171].  The presence of cumulus cells on immature 
oocytes has been reported to be beneficial to oocytes during the addition or removal of 
cryoprotectants by offering a rigid structure that protects against morphological damage resulting 
from osmotic and toxic effects [7].   
 
The low cleavage and blastocyst rates in the vitrified groups indicate that cooling had detrimental 
effects on the COCs.  This may be due to intracellular ice crystallization resulting from 
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insufficient time for cryoprotectants to cross the cumulus layer and permeate the oocytes.  It has 
been reported that cryopreservation of oocytes results in several ultrastructural and 
morphological alterations including abnormal distribution of chromosomes, microtubules and 
actin microfilaments [150, 172].  Additionally, damage to gap junction integrity can result in 
disruption of the communication between cumulus cells and oocytes [109, 147].  These 
morphological changes have been linked to failure in fertilization and embryo development [81, 
173].  During vitrification and warming in the present studies, ultra-rapid temperature changes 
may have resulted in damage to the membrane and ooplasm, as a result of intracellular ice 
formation.  Consequently, disruptions in protein synthesis and the failure of cumulus cell 
expansion and further meiotic development may have been responsible for the fertilization and 
subsequent embryo development failure [174].  Therefore, it is very important to confirm glass 
phase transition in the oocyte during vitrification to corroborate the absence of ice crystal 
formation.            
 
In addition to the osmotic stress resulting from exposure to high concentrations of cryoprotectant 
solutions, oocytes may also undergo dramatic volume changes during warming.  During this 
process, oocytes are rehydrated while cryoprotectants and water are exchanged across the 
concentration gradient [159].  However, one of the most important factors affecting cell survival 
during dilution is excessive cell swelling.  Water moves through the membrane faster than 
cryoprotectants and because of the high concentration of cryoprotectants remaining in the cell, 
water is drawn in and swelling occurs.  It has been shown that volume fluctuations can affect the 
integrity of the plasma membrane as well as the cytoskeletal organization of oocytes [160].  
Exposure to a warming solution is important for the removal of penetrating cryoprotectants from 
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oocytes; however, the ideal time is unknown.  In Experiment 2, exposing oocytes to the warming 
solution for 1 vs 5 min intervals appeared to have no obvious differences on subsequent 
developmental competence, indicating that longer warming solution exposure may not have 
added benefits.  However, 1 min may not be ideal, as indicated by the low blastocyst rates and 
further investigation into the optimal warming interval is required.  
 
The cleavage and blastocyst rates in all groups in Experiment 2 were noticeably lower than in 
Experiment 1.  This could be attributed to changes in the slaughterhouse procedures and shipping 
times and methods.  In Experiment 1, ovaries were shipped by courier over a distance of 220 km 
within 6 h of slaughter.  Due to unavoidable circumstances, ovaries for Experiment 2 came from 
a slaughterhouse 600 km away.  They had to be air-shipped, and often reached the lab more than 
8 h after slaughter.  The change in temperature and atmospheric pressure during shipping and 
exposure to x-ray security machines may have influenced cell signaling of the oocytes within the 
follicles of the ovaries and could account for the lower developmental rates in Experiment 2.    
 
In conclusion, the present studies indicated that exposure of immature bovine COCs to EG and 
DMSO based cryoprotectant solutions does not adversely affect subsequent fertilization and 
embryo development; however, ultra-rapid cooling to -196 °C (vitrification) clearly did.    
Furthermore, 5 min exposure to warming solution had no added benefits over 1 min, with 
regards to cleavage rates. The vitrification procedure had a severe adverse effect on cleavage of 
bovine oocytes and early embryo development. 
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CHAPTER 6: GENERAL DISCUSSION AND CONCLUSIONS 
 
Cryopreservation of mammalian oocytes has several applications.  The development of oocyte 
banks would allow for genetic improvement, global genetic transport, food security, long term 
preservation, maintenance of genetic diversity and breed regeneration and rescue.  Furthermore, 
the applications of assisted reproductive technologies (ART) in domestic animals require a large 
number of viable oocytes.  The cryopreservation of oocytes ensures their availability for ART.  
However, despite promising advancements in post-thaw survival of bovine semen and embryos, 
there are very few reports on the successful cryopreservation of bovine oocytes.  This is largely 
attributed to the lack of understanding of the fundamental cryobiological requirements of 
oocytes, especially those of cumulus oocyte complexes (COCs).       
 
Freezing rate is one of the most important factors in a cryopreservation protocol.  Currently there 
are two common methods for cryopreservation of mammalian COCs: conventional slow freezing 
and ultra-rapid freezing called “vitrification”.  During slow freezing, oocytes undergo slow and 
partial dehydration due to the formation of extracellular ice, through an equilibrium process 
involving the removal of water (osmosis).  Slow freezing is a common method for 
cryopreservation of embryos, and oocytes in species such as the mouse, cat, rabbit and humans 
which are not highly sensitive to cooling.  However, oocytes in species such as cattle and pigs 
have high lipid content and low membrane permeability, and consequently are more sensitive to 
chilling [9].  Upon freezing, the remaining intracellular water crystallizes, often resulting in cell 
damage.  One of the leading issues with slow freezing is prolonged exposure of COCs to 
cryoprotectants.  It is difficult to achieve an acceptable  freezing rate that avoids intracellular ice 
crystals, osmotic shock and the solution effect[9].  Slow freezing has also been shown to have 
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detrimental effects on COC metabolism.  An increase in intracellular calcium has been correlated 
with degeneration, apoptosis and parthenogenetic activation [175].  Moreover, mass 
spectrometry studies have identified drastic changes in protein expression in oocytes that 
underwent slow freezing, that are not present in vitrified oocytes [52, 176].       
 
Vitrification, originally developed for the cryopreservation of embryos, is a promising alternative 
for the cryopreservation of oocytes [38].  It solves a variety of biological problems associated 
with conventional freezing methods and has made cryopreservation more simple and convenient.  
The word vitrification is derived from the Latin word “Vitrum”, which means glass.  This 
approach uses high concentrations of cryoprotectants and ultra-rapid freezing rates to create an 
ice crystal-free, solid glass-like structure.  Glass transition, which prevents ice crystallization, 
occurs due to thermodynamics.  High concentrations of cryoprotectants bind with water and 
dehydrate the cells for a very short time, depressing the freezing point below -120 °C, the glass 
phase temperature. Upon ultra-rapid freezing, the viscous vitrification solution and cells within 
it, turn into a glass state without any intracellular ice formation [177].  Currently, vitrification is 
used for cryopreservation of embryos [178], ovarian tissues [179], ova [180], and whole ovaries 
[181].  Live offspring have been born from vitrified-warmed oocytes from the cow [112], horse 
[32] and human [97].  However, the overall success rate in terms of subsequent embryonic 
development has not been satisfactory in most species.   
 
Although vitrification prevents damage associated with ice crystallization, there are effects on 
oocyte (cellular) function, which can compromise their ability to develop normally.  Osmotic 
injury, toxic effects of cryoprotectants, concentrated intracellular electrolytes, chilling injury, 
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zona pellucida fracture and alterations to intracellular organelles, cytoskeleton and cell to cell 
contacts are the main factors contributing to compromised oocyte development following 
vitrification [48].  However, the severity and degree of damage to oocytes varies depending on 
many factors.  Cryoprotectant concentrations and exposure times, cryodevices, stage of 
maturation, cooling and warming rates and equilibration time in the warming solution all affect 
oocyte developmental competence following vitrification.  
 
The experiments presented in this thesis were undertaken in an attempt to develop methods for 
the cryopreservation of bovine oocytes utilizing vitrification procedures.  We examined the 
vitrification of bovine COCs using different equilibration times, packaging devices 
(cryodevices), oocyte maturation stages, cryoprotectant concentrations and equilibration, and 
warming intervals on nuclear maturation, and subsequent cleavage and embryo development 
following in vitro fertilization.   
 
In order to make the procedure more efficient and convenient, we examined the effect of 
preparing solutions in advance and storing them below 0 °C.  We hypothesized that vitrification 
of immature bovine oocytes in frozen-thawed vitrification solutions would result in lower 
cleavage rates and subsequent embryo development than when freshly prepared solutions were 
used.  We determined that vitrification and warming solutions can be stored for extended periods 
of time in the freezer with no effect on subsequent cleavage rates of COCs held in those 
solutions.  Therefore, in subsequent studies, vitrification solutions (VS1 and VS2) and the 
warming solution were prepared and stored in freezer (-20 °C) for convenience and to avoid 
batch-to-batch differences in these solutions.       
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Equilibrating COCs in vitrification solution 1 (VS1), which contains half of the concentrations of 
permeating cryoprotectants of vitrification solution 2 (VS2), is generally recommended to 
minimize the toxic and osmotic injuries of VS2.  However, removing the step of equilibration in 
VS1 would save time and the vitrification procedure would become more efficient by exposing 
oocytes to cryoprotectant solutions for a shorter period of time.  One of the objectives of this 
thesis was to examine the effect of equilibration on nuclear maturation, cleavage and blastocyst 
development.  In the first set of studies presented in this thesis, we hypothesized that 
equilibration of bovine COCs in VS1, before vitrification, is not essential for their subsequent 
nuclear maturation, cleavage and blastocyst development. Although there was no beneficial 
effect of equilibrating COCs in VS1 on post-warm nuclear maturation following vitrification, the 
cleavage rate was improved following equilibration inVS1 for 5 min vs 0 min.  It seems that 5 
min equilibration in VS1 is an appropriate time for penetration of cryoprotectants with minimum 
toxicity.   
 
Currently, the cryotop is a common device for the vitrification of mammalian embryos and 
oocytes.  It has been designed to minimize the volume of the vitrification solution surrounding 
the cells in order to achieve ultra-rapid cooling.  For vitrification of oocytes and embryos, the 
cryotop has been compared with other devices (cryoloop, open-pulled straw, electron microscope 
grids etc) and found to yield significantly higher survival rates than other devices [87, 99].  
However, the cryotop poses biosecurity risks because cells are exposed directly to liquid 
nitrogen, which is potentially contaminated with infectious agents.  Alternately, 0.25 mL straws 
can be used to avoid contamination.  However, the cooling rate in straw is not as rapid as with 
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the cryotop due to the volume of sample to be vitrified and the thickness of straw’s plastic wall.  
One of the objectives of this study was to compare the in vitro maturation of COCs vitrified in 
0.25 mL straws or cryotops.  We hypothesized that cryotop is a more efficient packaging system 
(cryodevice) than 0.25 mL straws for vitrification of bovine COCs.  Following warming, more 
oocytes reached metaphase II (MII) stage when vitrified using cryotops, suggesting that the more 
rapid cooling rate would yield higher survival rates following vitrification.  Consequently, the 
cryotop was used for all subsequent studies in this thesis.  However, further research on the 
development of a cryodevice that provides ultra-rapid cooling with no direct exposure to liquid 
nitrogen is necessary.              
 
Although the results are controversial, meiotic stage is thought to contribute to oocyte 
survivability following cryopreservation [50, 105-109].  Moreover, the preliminary data from our 
laboratory revealed that as compared to controls, vitrification of bovine COCs resulted in 
reduced maturation rates.  Therefore, we had to determine if our lab conditions were conducive 
for in vitro maturation of bovine COCs.  We hypothesized immature (GV stage) bovine oocytes 
would mature in vitro in 22 h.  Nearly 90% of oocytes were GV stage at the time of aspiration 
from ovarian follicles and 84% reached MII stage within 22 h, following the expected kinetics of 
oocyte maturation in our lab.  The results of this study provided substantial evidence for what 
nuclear stage oocytes can be expected to achieve follow different intervals of time in IVM 
medium in our laboratory, which was needed for subsequent studies in which oocytes were 
vitrified at different time intervals in IVM medium.  We hypothesized that the GV stage bovine 
oocytes at the time of vitrification would yield higher post-warm nuclear maturation and 
cleavage rates and subsequent embryo development.  However, there was no difference in the 
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proportions of oocytes reaching MII, undergoing cleavage and subsequently developing into 
embryos due to the stage of nuclear maturation at the time of vitrification.  It seemed that 
regardless of the stage of nuclear development, the developmental competence of the oocytes 
was compromised by vitrification.  Although the results of these studies indicated nuclear stage 
at the time of vitrification has no effect on in vitro maturation, cleavage and embryo 
development, it is unknown whether a longer interval of time in IVM (i.e. greater than 22 h) 
would increase the proportion of vitrified oocytes reaching MII.  A relatively high proportion of 
the oocytes vitrified at 0 h (GV stage) and 6 h (GV and GVBD stages), reached MI by 22 h.  
Perhaps a longer incubation time (24-26 h) would have given those oocytes a greater opportunity 
to complete nuclear maturation.       
  
Despite the critical importance of cryoprotectants for avoiding ice crystal formation, the higher 
concentrations of cryoprotectants required for vitrification may result in toxic and osmotic 
injuries to oocytes, leading to reduced developmental competence [156, 158].  During 
equilibration, oocytes are placed in a hypertonic solution.  In order to reach equilibrium, water 
moves out through the cell membrane and the oocyte shrinks.  Cryoprotectants move through the 
membrane into the cell at a rate that is much slower than the rate of water leaving the cell [182].  
As a result, the intracellular solute concentrations increase drastically, which can be very toxic to 
oocytes.  Eventually the oocyte re-expands due to influx of water following cryoprotectants.  
However, oocytes have limited tolerance to shrinkage and swelling and this process often causes 
osmotic shock, which can result in damage to the cytoskeleton.  During dilution, extensive 
swelling can also lead to osmotic shock resulting in membrane lysis and ultimately death of the 
oocyte [183].  Therefore, we hypothesized that exposure of bovine COCs to cryoprotectant 
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solutions affects their ability to become fertilized, cleave and subsequently develop into 
blastocysts and that the higher concentrations of cryoprotectant solutions used in vitrification 
procedures have toxic effects on bovine COCs, resulting in reduced cleavage and embryonic 
development.   To test these hypotheses, we examined the cleavage and blastocyst development 
rates of immature COCs exposed to VS1, VS2 and warming solutions and found no apparent 
negative effects of cryoprotectants, as indicated by similar cleavage and blastocyst rates between 
the control and cryoprotectant exposed groups.  From these studies, we concluded that the 
cryoprotectant solutions used in these experiments were likely not causing damage responsible 
for low development rates following vitrification of bovine COCs.  However, further studies are 
required to quantify cryoprotectant permeation, using nuclear magnetic resonance technology 
[184].  Compared to the control and cryoprotectant exposed groups, the vitrified groups had 
reduced cleavage and blastocyst production rates, suggesting a higher sensitivity of bovine COCs 
to cooling rather than cryoprotectants per se.   
 
The low maturation, cleavage and blastocyst rates of bovine oocytes that occurred following 
vitrification in these studies indicate that the potential of COCs to develop normally was 
compromised.  Cryodamage has been reported to produce a disruption in protein synthesis and a 
failure of cumulus cell expansion and further meiotic development, resulting in fertilization 
failure [174].  Cryopreserved oocytes have been reported to have several ultrastructural and 
morphological alterations and abnormal distribution of chromosomes, microtubules and actin 
microfilaments as well as disorganization of the spindle apparatus leading to risk of 
chromosomal loss and aneuploidy, phase change of lipid bilayers and cytoplasm membrane lysis 
and nuclear fragmentation [150, 172].  These changes damage gap junction integrity, resulting in 
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disruption of the communication between cumulus cells and the oocyte [109, 147].  
Morphological changes following vitrification have been linked to failure in fertilization and 
embryo development [81, 173] as was observed in these studies; however, in spite of achieving 
acceptable cleavage rates, the exact cause of low developmental rates in the present studies is 
unknown.  We observed embryonic developmental arrest at the 4-8 cell stage following 
vitrification.   It is at this stage that embryos take over its own genome, so vitrification may have 
severely affected early embryonic genes or signal transduction pathways essentially required for 
their development.  Genes and enzymes connected to MAP kinase, stress kinase or apoptosis 
pathways would be worth studying to determine the possible causes of early embryonic arrest in 
vitrified oocytes.   
 
During vitrification, COCs are exposed to various chemical, mechanical and thermal stresses that 
could compromise their functions and may cause cell death.  The unfavorable developmental 
rates in the present studies could be a result of the ultra-rapid temperature changes during 
vitrification and warming, which may have caused extensive damage to membranes and 
structures in the ooplasm.  However, damage to COCs may have also been due to solution effects 
or ice crystal formation resulting from partial dehydration of oocytes and thus lack of glass 
phase.  Confirming the specific damage incurred to COCs during vitrification would be useful 
for applying strategies to improve their survival rate.  Although it was not confirmed in the 
present studies, it is very important to validate whether the solution (and COC) form a glass 
phase during vitrification rather than crystals in order to decrease cryoinjury.  Future directions 
should focus on confirming the glass phase during vitrification by using strategies such as 
Synchrotron Beamline Technology.  The Canadian Macromolecular Crystallography Facility 
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(CMCF) at the Canadian Light Source provides the facility to confirm the absence or presence of 
ice crystals using X-ray diffraction technique.  When present, ice crystals exhibit a powder 
diffraction pattern, and in the glass phase there is no powder diffraction pattern.  The use of this 
technology would be invaluable to develop more suitable solutions for the vitrification of bovine 
COCs.           
 
During warming, it is essential to remove cryoprotectants and rehydrate the oocyte [159].  
Oocyte swelling during warming (dilution) is an important factor that could affect survival; 
volume fluctuations (and especially swelling) are not well tolerated and can affect the plasma 
membrane integrity and cytoskeletal organization [160].  However, the most appropriate 
warming time for rehydration of vitrified COCs is still unclear, depending on the cryoprotectants 
used and their concentration, the constituents and temperature of the warming solution.  
Therefore, one of our objectives was to study the effect of time of exposure of bovine COCs to 
warming solutions (1 vs 5 min) on cleavage and subsequent embryo development.  Although we 
hypothesized that warming vitrified COCs for a longer interval would presumably improve the 
removal of intracellular cryoprotectants resulting in higher cleavage and blastocyst production 
rates, our results indicated no difference between 1 and 5 min warming time.  This led us to 
conclude that a longer interval of exposure to the warming solution (5 min) was unnecessary and 
consequently, the procedure could be made more efficient.  However, in light of the low 
blastocyst rates, 1 min may not be optimal and further studies examining the interval of time in 
warming solutions are recommended.        
 
105 
 
From these studies, we found that vitrification adversely affected the ability of bovine oocytes to 
undergo in vitro maturation, in vitro fertilization and subsequent embryo development.  Cryotop 
was a superior cryodevice for vitrification of bovine COCs when compared with the 
conventional 0.25 mL straw and equilibration of bovine COCs in VS1 was not essential for their 
in vitro nuclear maturation, but appeared to be important for the fertilization process.  
Additionally, cryoprotectant exposure and the nuclear stage of oocytes at the time of vitrification 
appeared to have no effect on cleavage and embryo development, and there was no difference 
between 1 and 5 min warming time interval.  The results of these studies are pertinent for the 
future use of bovine oocyte cryopreservation, which despite recent advancements, is not yet a 
well established procedure.  The techniques used in these studies can be considered important 
steps in the development of a feasible approach for long term storage of female animal genetics.   
 
In order to achieve successful vitrification of bovine oocytes, an optimal balance between 
minimizing toxic and osmotic injury and maximizing the benefits of cryoprotectants needs to be 
elucidated.  Although considerable efforts have been made to produce mathematical models and 
sophisticated equipment, as well as to analyze physical, chemical and biological factors, there 
has been minimal success [185].  Further insight into the volumetric responses of matured 
oocytes to changes in osmolarity during preparation for cooling is necessary before the toxic and 
osmotic effects of cryoprotectants on COCs can be countered or mitigated.  There is also a need 
for additional studies to understand the mechanisms involved in cytoskeleton and cell membrane 
damage during bovine COCs vitrification in order to improve post-thaw cleavage and blastocyst 
rates.  Furthermore, continued investigation into the importance of structural/functional 
relationships to normal gene expression, protein translation, intracellular trafficking, epigenetic 
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modifications and cell development will help to better understand developmental consequences 
resulting from cryopreservation of COCs [52].   
 
Future directions of bovine COC cryopreservation research should include studying alterations 
of the lipid membrane composition in order to improve chilling resistance.  Avenues aimed at 
increasing cooling and warming rates in a practical fashion in order to pass COCs through the 
critical temperature zone quickly should continue to be examined.  Although liquid nitrogen-
mediated disease transmission is a rare event, it is an area of concern that needs more attention.  
Finding more practical means for reducing disease risk is critical before widespread application 
of oocyte banking occurs.  Currently there are no stringent criteria to assess COC quality, other 
than number of layers of cumulus cells and cytoplasm morphology.  Research finding evaluation 
markers, such as gene expression in the cumulus cells correlated with developmental rates could 
be used as a marker for COC quality before freezing, helping to select the COCs most suitable 
for cryopreservation.  Although nuclear maturation following vitrification was examined in this 
thesis, confirmation of cytoplasmic maturation following vitrification of COCs is also essential.        
 
The studies presented in this thesis are merely stepping stones in the pursuit of successful long 
term storage of mammalian oocytes.  The future of this research field holds great challenges, but 
also great promise.  
 
“Every great improvement has come after repeated failures. Virtually nothing comes out right the 
first time. Failures, repeated failures, are finger posts on the road to achievement. One fails forward 
toward success.”  -Charles F. Kettering 
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APPENDICES 
A.  Culture mediums and reagents    
Name Manufacturer Catalog No. Amount 
7X Laboratory Detergent (ICN7667094) MP Biomedicals 76-670-94 1 Gallon 
Albumin, Bovine (crystallized and lyophilized) SIGMA A4378 25 g 
Albumin, Bovine (Fatty Acid Free) SIGMA A-6003 10 g 
BME Amino Acids Solution SIGMA B6766 100 mL 
Calcium Chloride dihydrate (CaCl2 2H2O) SIGMA C-7902 500 g 
Calf Serum GIBCO 26010-074 500 mL 
Dulbecco's Phosphate Buffered Saline (+Ca/Mg) GIBCO 14040 500 mL 
FSH Folltropin  Bioniche 867357   
Gentamicin sulfate SIGMA G-1264 1 g 
L-Glutamic Acid SIGMA G-8540   
Heparin SIGMA H-3149 10000 unit 
HEPES SIGMA H-6147 25 g 
Hypotaurine SIGMA H-1384 100 mg 
(+)-Lactic Acid (Hemicalucim salt: Hydrate) SIGMA L-4388 50 g 
LH Bioniche E092A   
Magnesium Chloride hexahydrate (MgCl2 6H2O) SIGMA M-2393 100 g 
Medium 199 GIBCO 12340-030 500 mL 
MEM non-essential amino acid solution  GIBCO/Invitrogen 11140-050 100 mL 
Mineral Oil Aldrich 161403-1L 1000 mL 
Percoll SIGMA P-1644 500 mL 
Phenol Red SIGMA P-0290 100 mL 
Potassium Chloride (KCl) SIGMA P-5405 50 
Sodium Bicarbonate (NaHCO3) SIGMA S-4019 500 g 
Sodium Chloride (NaCl) SIGMA S-5886 1 kg 
Sodium Dihydrogen Phosphate Dihydrate FLUKA 71505 1 kg 
Sodium Pyruvate SIGMA P4562-25G   
Water SIGMA W-1503 500 mL 
Saline     500-1000 mL 
EG SIGMA     
DMSO SIGMA     
Sucrose SIGMA     
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B.  Equipment and materials   
Equipment Manufacturer Cat No. 
Disposable centrifuge tubes VWR 21008-929 
Absorbent bench underpads VWR 56617-018 
Millex GP filter (0.22 um) Millipore SLGP033RS 
Petri Dish 35mm VWR 25382-064 
Petri Dish 60mm VWR CA25382-100 
Petri Dishes 100 mm Fisher 08-757-12 
Spatulas VWR   57952-107 
Weigh Paper VWR 12578-121 
100 mL Graduated Cylinders VWR 89001-100 
250 mL Graduated Cylinder     
500 mL Graduated Cylinder     
Pipette Tips (all sizes) mjs biolynx   
.1-10 µL mjs biolynx US 11103700 
1-200 µL mjs biolynx US 11110700 
100-1000 µL mjs biolynx US 11112720 
Parafilm     
20 mL syringes VWR 53548-008 
Tissue Flasks (50 mL) VWR CA29184-801 
Glass Bottles (100 mL) VWR KT321000-0100 
Pasteur Pipettes VWR CA14672-380 
50 mL Beakers     
100 mL Beakers VWR 89003-784 
250 mL Beakers VWR 89003-788 
500 mL Beaker     
Falcon Tubes (15 mL) VWR 21008-918 
Falcon Tubes (50 mL) VWR 21008-951 
Centrifuge     
Water Aspirator     
Hemocytometer (Neuabauer Chamber)     
Weigh Scale     
1000-5000 µL Pipette     
1000-5000 µL Pipette Tips Biolynx 1053-0710 
Bunsen Burner     
Large Filters (500 mL) VWR 28199-585 
Large Filters (250 mL) VWR 28199-677 
Eppendorf Tubes (1.5 mL) VWR 89000-028 
Vortex     
Broken Glass Container Fisherbrand 12-009-7A 
 
 
 
